
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29416704</article-id><article-id pub-id-type="pmc">5787449</article-id><article-id pub-id-type="publisher-id">22840</article-id><article-id pub-id-type="doi">10.18632/oncotarget.22840</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>LncRNAs regulate cancer metastasis via binding to functional proteins</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Liting</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Yanyan</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Shanshan</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Can</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Ming</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Ni</given-names></name><xref ref-type="aff" rid="A5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiaoling</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Guiyuan</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Zhaoyang</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><aff id="A1"><sup>1</sup> The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, Hunan, China</aff><aff id="A2"><sup>2</sup> The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China</aff><aff id="A3"><sup>3</sup> Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China</aff><aff id="A4"><sup>4</sup> Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China</aff><aff id="A5"><sup>5</sup> Core Laboratory, Shenzhen Second People&#x02019;s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China</aff><aff id="A6"><sup>6</sup> Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA</aff></contrib-group><author-notes><corresp id="cor1"><bold><italic>Correspondence to: </italic></bold><italic>Zhaoyang Zeng,</italic><email>zengzhaoyang@csu.edu.cn</email></corresp><corresp id="cor2"><italic>Fang Xiong,</italic><email>xiongf@csu.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><day>2</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>1</day><month>12</month><year>2017</year></pub-date><volume>9</volume><issue>1</issue><fpage>1426</fpage><lpage>1443</lpage><history><date date-type="received"><day>5</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2018 Yang et al.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Cancer is one of the leading causes of death worldwide, and metastasis is a crucial characteristic of malignancy. Recent studies have shown that lncRNAs play an important role in regulating cancer metastasis through various molecular mechanisms. We briefly summarize four known molecular functions of lncRNAs, including their role as a signal, decoy, guide and scaffold. No matter which pattern lncRNAs follow to carry out their functions, the proteins that lncRNAs bind to are important for them to exhibit their gene-regulating properties. We further illustrate that lncRNAs regulate the localization, stabilization or modification of their binding proteins to realize the binding role of lncRNAs. In this review, we focus on the interactions between lncRNAs and their binding proteins; moreover, we focus on the mechanisms of the collaborative work of lncRNAs and their binding proteins in cancer metastasis, thus evaluating the potential of lncRNAs as prospective novel therapeutic targets in cancer.</p></abstract><kwd-group><kwd>lncRNA</kwd><kwd>functional proteins</kwd><kwd>metastasis</kwd><kwd>localization</kwd><kwd>stabilization</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>BACKGROUND</title><p>Cancer is one of the leading causes of death worldwide, and as one of the hallmarks of cancer, metastasis is a crucial characteristic of malignancy [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>]. Metastasis is a complex multistep process that involves the early invasion and late colonization of cancer cells [<xref rid="R3" ref-type="bibr">3</xref>]. Usually, cancer cells undergo morphological alterations and change their cell-cell or cell-matrix interactions to be able to successfully pass through the first steps of the multistep process of metastasis [<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>]. EMT (epithelial-mesenchymal transition) is of critical importance in the early events of tumor cell metastatic dissemination by endowing the cells with a more motile, invasive potential [<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref>]. On the other hand, MET (mesenchymal-epithelial transition) is required for migrating cells to extravasate from the vessels into their target tissues to form micrometastases and eventually form a secondary tumor after the cells survive anoikis [<xref rid="R16" ref-type="bibr">16</xref>].</p><p>LncRNAs (long non-coding RNAs) are a class of transcripts longer than 200 nucleotides with limited protein coding potential [<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R22" ref-type="bibr">22</xref>]. In the past, extensive efforts have been made to characterize the involvement of protein-coding genes in cancer metastasis but few for lncRNAs, which have once been thought as the &#x0201c;dark matter&#x0201d; of the genome, because of our limited knowledge about their functions. Up to now, more and more studies have identified that deregulations of lncRNAs are observed in various cancer types, and an abnormal expression of lncRNAs virtually participates in all stages of cancer development, including cancer initiation, progression and metastasis [<xref rid="R23" ref-type="bibr">23</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref>].</p><p>Various modes of molecular interactions were observed for lncRNAs to exhibit their gene-regulating properties in the recent years. Studies indicate that lncRNAs bind to proteins and regulate their functions. In this review, we summarize the role of lncRNAs binding to functional proteins to regulate their localization, stabilization or modification in cancer metastasis.</p><sec id="s1_1"><title>LncRNAs regulate cancer metastasis through multiple signaling pathways</title><p>Metastasis of cancer cells to a distal site is a particularly critical stage of cancer progression [<xref rid="R30" ref-type="bibr">30</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref>]. EMT is a critical process during the initiation of cancer metastasis, the changes in this program includes cell morphology, cell-matrix adhesion and migration abilities. E-cadherin, intergrins, and cytokeratins are the most commonly used epithelial markers, while N-cadherin, vimentin and fibronectin are mesenchymal markers [<xref rid="R10" ref-type="bibr">10</xref>]. A group of EMT-inducing transcription factors, including Slug, Snail and ZEB1/2 (zinc finger E-box binding homeobox 1/2), are activated during EMT [<xref rid="R37" ref-type="bibr">37</xref>]. Growth signals from the tumor stroma, such as TGF-&#x003b2; (transforming growth factor) [<xref rid="R38" ref-type="bibr">38</xref>&#x02013;<xref rid="R41" ref-type="bibr">41</xref>], EGF (epidermal growth factor), FGF (fibroblast growth factor), PDGF (platelet-derived growth factor), IGF (insulin growth factor) and HGF (hepatocyte growth factor), are responsible for triggering EMT in cancer cells [<xref rid="R42" ref-type="bibr">42</xref>&#x02013;<xref rid="R45" ref-type="bibr">45</xref>]. These inducers trigger EMT through a complex signaling network, including several receptor tyrosine kinases (RTKs) and the TGF-&#x003b2;/SMAD, WNT/&#x003b2;-catenin, NOTCH, MAPK/ERK, PI3K/Akt and HEDGEHOG signaling pathways [<xref rid="R46" ref-type="bibr">46</xref>&#x02013;<xref rid="R60" ref-type="bibr">60</xref>]. The aberrant expression of lncRNAs plays a considerable role in cancer metastasis, and they have emerged as versatile regulators of the EMT related pathways mentioned above (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>LncRNAs act as regulators of metastasis-related signaling pathways</title><p>An aberrant expression of lncRNAs promotes cancer metastasis via the TGF-&#x003b2;/SMAD, WNT/&#x003b2;-catenin, NOTCH, MAPK/ERK, PI3K/Akt and HEDGEHOG signaling pathways.</p></caption><graphic xlink:href="oncotarget-09-1426-g001"/></fig><p>The TGF-&#x003b2; signaling pathway is one of the major pathways responsible for the induction of EMT via a group of transcription factors, including Slug, Snail and Twist [<xref rid="R61" ref-type="bibr">61</xref>, <xref rid="R62" ref-type="bibr">62</xref>]. <italic>LncRNA-HIT</italic> (LncRNA-HOXA transcript induced by TGF-&#x003b2;) is one of the most upregulated lncRNAs induced by TGF-&#x003b2; [<xref rid="R63" ref-type="bibr">63</xref>]. The upregulation of <italic>LncRNA-HIT</italic> promotes the migration and invasion of NSCLC by directly associating with ZEB1 [<xref rid="R64" ref-type="bibr">64</xref>]. The knock down of <italic>lncRNA-ATB</italic> impedes the induction of EMT by TGF-&#x003b2; in HCC and colon cancer [<xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R66" ref-type="bibr">66</xref>]. <italic>ZEB2-AS1</italic>, <italic>MALAT1</italic> and <italic>linc01133</italic> also play a critical role in the TGF-&#x003b2; signaling pathway [<xref rid="R67" ref-type="bibr">67</xref>&#x02013;<xref rid="R69" ref-type="bibr">69</xref>].</p><p>The canonical WNT/&#x003b2;-catenin pathway also plays an important role in the regulation of cancer metastasis [<xref rid="R70" ref-type="bibr">70</xref>, <xref rid="R71" ref-type="bibr">71</xref>]. &#x003b2;-catenin is a core component of the cadherin protein complex, whose localization and stabilization are essential for the activation of WNT/&#x003b2;-catenin signaling [<xref rid="R72" ref-type="bibr">72</xref>, <xref rid="R73" ref-type="bibr">73</xref>]. Several lncRNAs are involved in WNT/&#x003b2;-catenin pathway regulation. For example, <italic>HOTAIR</italic> (HOX transcript antisense RNA) epigenetically silences the Wnt inhibitor WIF1, while the loss of WIF1 enhances the migratory ability of glioblastoma cells through WNT5A activation mediated via <italic>MALAT1</italic> [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>]. The <italic>lncRNA H19</italic>, <italic>TINCR</italic>, and <italic>lncTCF7</italic> also play critical roles in the regulation of cancer metastasis via the WNT/&#x003b2;-catenin pathway [<xref rid="R76" ref-type="bibr">76</xref>&#x02013;<xref rid="R78" ref-type="bibr">78</xref>].</p><p>MAPK/ERK signaling is an element in lncRNAs that mediates the regulation of metastasis. <italic>MALAT1</italic> promotes the metastasis of gallbladder carcinoma through the activation of the MAPK/ERK pathway [<xref rid="R79" ref-type="bibr">79</xref>]. <italic>UCA1</italic> (lncRNA urothelial carcinoma-associated 1) plays a pivotal role in the tumorigenesis of HCC by acting as a ceRNA for miR-216b, leading to the suppression of FGFR1 (fibroblast growth factor receptor 1) expression and the activation of the MAPK/ERK signaling pathway [<xref rid="R80" ref-type="bibr">80</xref>].</p><p>In addition to their roles in the pathways mentioned above, several lncRNAs also utilize the PI3K/Akt signaling pathway in metastasis regulation. <italic>Linc00152</italic> directly binds with EGFR, which activates PI3K/Akt signaling in gastric cancer [<xref rid="R81" ref-type="bibr">81</xref>]. The downregulation of <italic>MALAT1</italic> induces EMT via the PI3K/Akt pathway in breast cancer [<xref rid="R82" ref-type="bibr">82</xref>], and in contrast, the upregulation of MALAT1 promotes the metastasis of osteosarcoma cells by activating the PI3K/Akt pathway [<xref rid="R83" ref-type="bibr">83</xref>].</p><p>LncRNAs regulate metastasis using additional pathways, such as the Notch and Hedgehog signaling pathways [<xref rid="R84" ref-type="bibr">84</xref>&#x02013;<xref rid="R88" ref-type="bibr">88</xref>]. There are so many patterns for lncRNAs to regulate cancer metastasis, and thus, a particular focus on the molecular mechanisms of lncRNAs in metastasis is needed.</p></sec><sec id="s1_2"><title>Roles of lncRNAs in regulating protein functions</title><p>LncRNAs use various modes of molecular interactions to exhibit their gene-regulating properties from transcriptional to posttranscriptional regulation. The functional domains of lncRNAs include RNA-binding domains, DNA-binding domains and protein-binding domains [<xref rid="R89" ref-type="bibr">89</xref>]. Thanks to structural plasticity, lncRNAs can act as signals, decoys, guides and scaffolds [<xref rid="R90" ref-type="bibr">90</xref>].</p><p>LncRNAs show a type-specific expression and respond to various stimuli, suggesting that lncRNAs can serve as molecular signals [<xref rid="R90" ref-type="bibr">90</xref>]. As signals, lncRNAs mark space, time, and expression for gene regulation. For instance, <italic>lincRNA-p21</italic> is a transcriptional target of p53 and plays a role in triggering apoptosis [<xref rid="R91" ref-type="bibr">91</xref>]. Other lncRNAs, such as <italic>HOTAIR</italic> [<xref rid="R92" ref-type="bibr">92</xref>] and <italic>Xist</italic> (X-inactive-specific-transcript) [<xref rid="R93" ref-type="bibr">93</xref>], also function as signals, and they usually serve as markers of biological events and are capable of delivering further signals.</p><p>LncRNAs act as molecular decoys, because they possess an RNA motif, which binds and titrates away proteins or RNA targets. Some lncRNAs, acting as a &#x0201c;sponge&#x0201d; of miRNAs, also belong to this archetype. In this type, lncRNAs function as CeRNAs (competing endogenous RNA), and vie with mRNAs for miRNAs with shared MREs (miRNAs responses elements) and act as a modulator of miRNAs by influencing the available level of miRNAs [<xref rid="R94" ref-type="bibr">94</xref>, <xref rid="R95" ref-type="bibr">95</xref>]. Sponge LncRNAs, such as <italic>H19</italic> [<xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R96" ref-type="bibr">96</xref>&#x02013;<xref rid="R99" ref-type="bibr">99</xref>], <italic>HOTAIR</italic> [<xref rid="R100" ref-type="bibr">100</xref>&#x02013;<xref rid="R102" ref-type="bibr">102</xref>], MALAT1 [<xref rid="R69" ref-type="bibr">69</xref>, <xref rid="R103" ref-type="bibr">103</xref>&#x02013;<xref rid="R107" ref-type="bibr">107</xref>], <italic>UCA1</italic> [<xref rid="R108" ref-type="bibr">108</xref>&#x02013;<xref rid="R111" ref-type="bibr">111</xref>], <italic>XIST</italic> [<xref rid="R112" ref-type="bibr">112</xref>, <xref rid="R113" ref-type="bibr">113</xref>], <italic>HULC</italic> [<xref rid="R114" ref-type="bibr">114</xref>], <italic>lincRNA-ROR</italic> [<xref rid="R115" ref-type="bibr">115</xref>], <italic>lnc-FTX</italic> [<xref rid="R116" ref-type="bibr">116</xref>], <italic>NEAT1</italic> [<xref rid="R117" ref-type="bibr">117</xref>, <xref rid="R118" ref-type="bibr">118</xref>], <italic>SNHG1</italic> [<xref rid="R119" ref-type="bibr">119</xref>], <italic>TUG1</italic> [<xref rid="R120" ref-type="bibr">120</xref>], and <italic>TUSC7</italic> [<xref rid="R121" ref-type="bibr">121</xref>], are typical examples.</p><p>The third molecular role of lncRNAs is a guide. By acting as a guide, lncRNAs bind to proteins and then direct the localization of the resultant complex to specific targets [<xref rid="R90" ref-type="bibr">90</xref>]. Guide lncRNAs directly interact with DNA and RNA by base pairing, and highly structured lncRNAs also provide docking sites for binding proteins [<xref rid="R122" ref-type="bibr">122</xref>]. For example, lncRNA <italic>HOTTIP</italic> directly binds the adaptor protein WDR5 and targets WDR5/MLL complexes to the <italic>HOXA</italic>, increasing the H3 lysine 4 trimethylation of the HOXA cluster to cause gene transcription [<xref rid="R90" ref-type="bibr">90</xref>]. There are many other lncRNAs that function as guides, such as <italic>HOTAIR</italic> [<xref rid="R92" ref-type="bibr">92</xref>] and <italic>SChLAP1</italic> [<xref rid="R123" ref-type="bibr">123</xref>].</p><p>The fourth function of lncRNAs is a scaffold. LncRNAs serve as central platforms on which different effector molecules are assembled. The function of LncRNAs as scaffolds is perhaps the most functionally intricate and complex class, in which the lncRNAs possess different domains that bind distinct effector molecules [<xref rid="R90" ref-type="bibr">90</xref>]. One example is Kcnq1ot1, which binds both PRC2 and G9a to promote H3K27me3 and H3K9me3 [<xref rid="R124" ref-type="bibr">124</xref>]. Other lncRNAs such as <italic>ANRIL</italic> (CDKN2B antisense RNA 1) [<xref rid="R125" ref-type="bibr">125</xref>, <xref rid="R126" ref-type="bibr">126</xref>], <italic>HOTAIR</italic> [<xref rid="R127" ref-type="bibr">127</xref>], and <italic>GClnc1</italic> (gastric cancer-associated lncRNA 1) [<xref rid="R128" ref-type="bibr">128</xref>] also function as scaffolds to regulate gene expression.</p><p>As a whole, the archetypes mentioned above are not mutually exclusive. LncRNAs play regulatory functions through either RNA-protein or RNA-DNA recognition rules. No matter which archetype lncRNAs carry out their functions, the proteins they bind to are important for them to exhibit their metastasis-regulating performances. In general, lncRNAs complex with various proteins to regulate their localization, stabilization or modification.</p></sec><sec id="s1_3"><title>LncRNAs regulate the localization of binding proteins</title><p>Chromatin-modifying proteins are a major group of lncRNA binding proteins, and lncRNAs bind to and guide them to specific sites in the genome to regulate metastasis-related genes expression in space and time. A prominent example of a histone-modifying complex interacting with lncRNAs is PRC2, a histone methyltransferase that catalyzes the mono-, di- and trimethylation of H3K27, which is required for epigenetic silencing during development and cancer. The core PRC2 complex is composed of four proteins, including EZH1/2, SUZ12, EED and RbAP46/48 [<xref rid="R129" ref-type="bibr">129</xref>]. Until now, the question of how the histone-modifying complex identifies its binding sites on the chromatin remains open, and studies on lncRNAs may give us new and exciting answers. <italic>HOTAIR</italic>, a lncRNA first identified by Rinn et al., interacts with PRC2 and is required for PRC2 occupancy on the HOXD locus [<xref rid="R92" ref-type="bibr">92</xref>]. Later, researchers found that <italic>HOTAIR</italic> is upregulated in different kinds of cancers and promotes cancer metastasis through by regulating the localization of PRC2 [<xref rid="R130" ref-type="bibr">130</xref>&#x02013;<xref rid="R133" ref-type="bibr">133</xref>]. Mechanistically, HOTAIR recruits the PRC2 complex to specific target genes genome-wide, leading to H3K27 trimethylation and epigenetic silencing of metastasis suppressor genes. LncRNAs also functions as molecular scaffold to link PRC2 and other modification proteins [<xref rid="R127" ref-type="bibr">127</xref>, <xref rid="R134" ref-type="bibr">134</xref>&#x02013;<xref rid="R136" ref-type="bibr">136</xref>]. For example, HOTAIR functions as a molecular scaffold to link and target the histone modification complexes PRC2 and LSD1 and then reprograms chromatin states by coupling histone H3K27 methylation and H3K4 demethylation for epigenetic gene silencing to promote cancer metastasis (Figure <xref ref-type="fig" rid="F2">2A</xref>).</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>LncRNAs regulate the localization of the chromatin modification complex</title><p><bold>(A)</bold> HOTAIR functions as a molecular scaffold to link and target PRC2 and LSD1, which then reprograms chromatin states by coupling histone H3K27 methylation and H3K4 demethylation for epigenetic gene silencing to promote cancer metastasis. <bold>(B)</bold> SChLAP1 interacts with SNF5 and functions as a molecular decoy that sequesters the SWI/SNF chromatin-modifying complex away from selective gene loci to regulate gene expression. <bold>(C)</bold> GClnc1 upregulates the transcription of SOD2 by acting as a scaffold to recruit the WDR5 and KAT2A complex to the SOD2 promoter, increasing H3K4 trimethylation and H3K9 acetylation levels in the SOD2 promoter region. <bold>(D)</bold> ZEB1-AS1 directly binds and recruits p300 to the ZEB1 promoter, which induces an open chromatin structure and activates ZEB1 transcription. <bold>(E)</bold> SLNCR1 binds to AR and Brn3a. The SLNCR1/AR/Brn3a ternary complex, located upstream of the MMP9 transcription start site, increases MMP9 expression. <bold>(F)</bold> BCAR4 binds to SNIP1 and PNUTS. In response to cytokine stimulation, BCAR4 lifts the inhibitory effect of SNIP1 on p300, leading to the acetylation of histones, which in turn leads to the activation of polymerase II at GLI2 controlled genes.</p></caption><graphic xlink:href="oncotarget-09-1426-g002"/></fig><p>Another example is <italic>SChLAP1</italic>, which is a lncRNA upregulated in prostate cancer. <italic>SChLAP1</italic> promotes prostate cancer invasiveness and metastasis by binding to SWI/SNF and titrating it away from the chromatin [<xref rid="R123" ref-type="bibr">123</xref>]. The mammalian SWI/SNF complex mediates ATP-dependent chromatin remodeling processes, and a substantial of evidence indicates that several components of the SWI/SNF complexes function as tumor suppressors [<xref rid="R137" ref-type="bibr">137</xref>]. In detail, <italic>SChLAP1</italic> interacts with SNF5 (also known as SMARCB1, an essential subunit that facilitates SWI/SNF binding to histone proteins) and functions as a molecular decoy that sequesters the SWI/SNF chromatin-modifying complex away from the selective gene loci to inhibit metastasis suppressor gene expression (Figure <xref ref-type="fig" rid="F2">2B</xref>).</p><p>MLL1 is a member of the evolutionarily conserved SET1 family of histone H3 lysine4 (H3K4) methyltransferases, which are required for the regulation of distinct groups of developmentally regulated genes [<xref rid="R138" ref-type="bibr">138</xref>, <xref rid="R139" ref-type="bibr">139</xref>]. WDR5 is a core subunit of MLL1 and acts as an &#x0201c;effector&#x0201d; of H3K4 methylation in gene transactivation [<xref rid="R128" ref-type="bibr">128</xref>]. Sun et al. identified a novel lncRNA, <italic>GClnc1</italic>, which promotes gastric cancer metastasis [<xref rid="R106" ref-type="bibr">106</xref>]. In detail, <italic>GClnc1</italic> upregulates the transcription of <italic>SOD2</italic> (dismutase 2 mitochondrial) by acting as a scaffold to recruit the WDR5 and KAT2A (histone acetyltransferase) complex to the <italic>SOD2</italic> promoter and increasing the H3K4 trimethylation and H3K9 acetylation levels in the <italic>SOD2</italic> promoter region (Figure <xref ref-type="fig" rid="F2">2C</xref>). Upregulated <italic>SOD2</italic> expression consequently promotes metastasis.</p><p>p300 is a HAT (histone acetyltransferase) member that acetylates histone proteins by transferring an acetyl group from acetyl-CoA to specific lysine residues [<xref rid="R140" ref-type="bibr">140</xref>]. The acetylation of histones by HATs results in a dispersed structure of chromatin, which becomes accessible to transcriptional factors [<xref rid="R141" ref-type="bibr">141</xref>]. <italic>ZEB1-AS1</italic> promotes cell migration in osteosarcoma by directly binding and recruiting p300 to the <italic>ZEB1</italic> promoter, which induces an open chromatin structure and activates <italic>ZEB1</italic> transcription [<xref rid="R142" ref-type="bibr">142</xref>] (Figure <xref ref-type="fig" rid="F2">2D</xref>).</p><p>In addition to chromatin-modifying proteins, transcription factors also interact with lncRNAs. A study identified that lncRNAs guide transcription factors to specific sites in the genome. For example, <italic>SLNCR</italic> (SRA-like non-coding RNA) contains a conserved&#x0223c;300 nucleotide region with a significant similarity to steroid receptor RNA activator 1 (SRA1). Schmidt et al. [<xref rid="R143" ref-type="bibr">143</xref>] reported that Brn3a (a member of the Brn 3 family of POU-domain transcription factors) and AR (a steroid-hormone activated transcription factor) bind to <italic>SLNCR1</italic>&#x02019;s conserved sequence and an adjacent sequence, respectively. The SLNCR1/AR/Brn3a ternary complex has a high affinity for the AR and Brn3a binding sites located upstream of the <italic>MMP9</italic> transcription start site, and the cooperative binding of AR and Brn3a to its promoter increases <italic>MMP9</italic> expression and activity and, thus, increases the invasion of melanoma cells (Figure <xref ref-type="fig" rid="F2">2E</xref>). Another prominent example is <italic>BCAR4</italic> (breast cancer anti-estrogen resistance 4), which contributes to tumor metastasis by binding to SNIP1 (SMAD nuclear interacting protein 1) and PNUTS (a phosphatase). In response to cytokine stimulation, <italic>BCAR4</italic> lifts the inhibitory effect of SNIP1 on p300, leading to the acetylation of histones, such as H3K18ac. Acetylated histones are necessary for the BCAR4-mediated recruitment of PNUTS, which in turn leads to the active polymerase II at GLI2 controlled genes [<xref rid="R144" ref-type="bibr">144</xref>] (Figure <xref ref-type="fig" rid="F2">2F</xref>).</p><p>The lncRNAs mentioned above guide the binding proteins to chromatin or titrate the binding proteins away from the chromatin to regulate gene expression directly. LncRNAs can also decoy the protein from it RNA targets or interact proteins. For example, <italic>LINC01133</italic>, which is downregulated by TGF-&#x003b2;, inhibits EMT and metastasis in colorectal cancer [<xref rid="R69" ref-type="bibr">69</xref>]. Mechanistically, <italic>LINC01133</italic> acts as key downstream molecule in the TGF-&#x003b2; pathway and inhibits the EMT in colorectal cancer by directly binding to SRSF6 (serine and arginine rich splicing factor 6) as a target mimic. The authors speculate that <italic>LINC01133</italic> may act as a decoy element, titrating SRSF6 away from it RNA targets by directly binding to its critical domain to block the induction of EMT. However, how SRSF6 regulates colorectal cancer cell EMT is still unknown. Another study found that <italic>MALAT1</italic> promotes colorectal cancer cell metastasis by competitively binding to PSF and releasing SFPQ from the SFPQ/PTBP2 (polypyrimidine tract binding protein 2) complex, which then increases the SFPQ-detached proto-oncogene PTBP2 [<xref rid="R145" ref-type="bibr">145</xref>].</p></sec><sec id="s1_4"><title>LncRNAs regulate the stabilization of binding proteins</title><p>Like all macromolecular components of an organism, the proteome is in a dynamic state of synthesis and degradation. The proteolytic equilibrium of the proteins is disturbed and the microenvironment is changed in pathophysiological conditions [<xref rid="R146" ref-type="bibr">146</xref>]. Studies find that lncRNAs play an important role in regulating the stabilization of binding proteins.</p><p><italic>TINCR</italic> (Terminal differentiation-induced lncRNA) was first reported by Markus et al. [<xref rid="R147" ref-type="bibr">147</xref>], and they declared that the 3.7-kilobase lncRNA controls human epidermal differentiation by a post-transcriptional mechanism. Then, Zhang et al. [<xref rid="R77" ref-type="bibr">77</xref>] found that the loss of <italic>TINCR</italic> expression promotes colorectal cancer metastasis by specifically binds to EpCAM, preventing its proteolysis. EpCAM is expressed at the basolateral membrane of most normal epithelial cells but is over-expressed in many epithelial cancers. The loss of <italic>TINCR</italic> promotes the hydrolysis of EpCAM and then releases EpICD (EpCAM c-term, intracellular domain), which is one of the components of the Wnt pathway, and colocalizes with FHL2 and &#x003b2;-catenin to form a nuclear protein complex, leading to gene transcription and, subsequently, activating the Wnt/&#x003b2;-catenin pathway [<xref rid="R77" ref-type="bibr">77</xref>, <xref rid="R148" ref-type="bibr">148</xref>] (Figure <xref ref-type="fig" rid="F3">3A</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>LncRNAs regulate the stabilization of binding proteins</title><p><bold>(A)</bold> TINCR binds to EpCAM and prevent its proteolysis. The loss of TINCR promotes the hydrolysis of EpCAM and releases EpICD. EpICD colocalizes with FHL2 and &#x003b2;-catenin to form a nuclear protein complex, leading to gene transcription. <bold>(B)</bold> LncRNA-LET binds to NF90 and enhances its degradation, thereby affecting HIF-1&#x003b1; mRNA accumulation and stability under hypoxic conditions, and the inactivation of HIF-1&#x003b1; results in the decreased expression of EMT-related proteins, thus leading to the inhibition of EMT, motility and invasiveness.</p></caption><graphic xlink:href="oncotarget-09-1426-g003"/></fig><p><italic>LncRNA-LET</italic> inhibits the metastasis of HCC and colorectal cancer cells, which are suppressed by HDAC3 (histone deacetylase 3) in hypoxia conditions [<xref rid="R149" ref-type="bibr">149</xref>]. A study found that <italic>lncRNA-LET</italic> functions through its association with NF90, which is a double-strand RNA-binding protein that has been implicated in the stabilization, transport, and translational control of many target mRNAs, including <italic>HIF-1&#x003b1;</italic> (hypoxia-inducible factor 1 alpha subunit) [<xref rid="R150" ref-type="bibr">150</xref>]. Mechanistically, <italic>lncRNA-LET</italic> binds to NF90 and enhances its degradation, which thereby affects <italic>HIF-1&#x003b1;</italic> mRNA accumulation and stability under hypoxic conditions, and the inactivation of <italic>HIF-1&#x003b1;</italic> results in the decreased expression of EMT-related proteins, leading to an inhibition of EMT, motility and invasiveness [<xref rid="R121" ref-type="bibr">121</xref>, <xref rid="R149" ref-type="bibr">149</xref>] (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p><p><italic>LncRNA-HIT</italic> promotes metastasis in NSCLC (non-small cell lung cancer) via specially binding to ZEB1 [<xref rid="R64" ref-type="bibr">64</xref>]. ZEB factors contain multiple domains that interact with other transcription factors, which is essential for the regulation of EMT [<xref rid="R151" ref-type="bibr">151</xref>, <xref rid="R152" ref-type="bibr">152</xref>]. Mechanistically, the association between <italic>LncRNA-HIT</italic> and ZEB1 protects ZEB1 from proteasome degradation. Upregulated <italic>LncRNA-HIT</italic> promotes migration and invasion via increasing the occupancy of ZEB on the promoter region of <italic>CDH1</italic> [<xref rid="R64" ref-type="bibr">64</xref>]. LncRNA <italic>AOC4P</italic> (amine oxidase, copper containing 4, pseudogene) is another lncRNA that regulates the EMT marker protein directly. LncRNA <italic>AOC4P</italic> suppress EMT in HCC by binding to vimentin, the major component of the cytoskeleton, and enhancing its degradation [<xref rid="R153" ref-type="bibr">153</xref>].</p></sec><sec id="s1_5"><title>LncRNAs regulate the post-translational modification of binding proteins</title><p>NF-kB is a family of transcription factors, and aberrant NF-kB activation promotes cancer invasion and metastasis [<xref rid="R154" ref-type="bibr">154</xref>&#x02013;<xref rid="R156" ref-type="bibr">156</xref>]. Liu et al. [<xref rid="R157" ref-type="bibr">157</xref>] identified the lncRNA <italic>NKILA</italic> (NF-KappaB Interacting LncRNA), which has a low expression in breast cancer and binds to the NF-kB / IkB complex. IkB (inhibitor of NF-kB) acts as a negative regulator of NF-kB by binding to and sequestering NF-kB in the cytoplasm. It is considered as a major brake in NF-kB signaling [<xref rid="R154" ref-type="bibr">154</xref>]. <italic>NKILA</italic> binds to the NF-kB / IkB complex and directly masks the phosphorylation motifs of IkB, which thereby inhibits IKK-induced IkB phosphorylation and NF-kB activation [<xref rid="R133" ref-type="bibr">133</xref>] (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>LncRNAs regulate the modification of binding proteins</title><p>NKILA binds to the NF-kB / IkB complex and directly masks the phosphorylation motifs of IkB, thereby inhibiting IKK-induced IkB phosphorylation and NF-kB activation.</p></caption><graphic xlink:href="oncotarget-09-1426-g004"/></fig><p>In addition to the three patterns lncRNAs use to regulate their binding proteins, lncRNA regulate binding proteins through other way. A high expression of GAPLINC (Gastric adenocarcinoma predictive long intergenic noncoding RNA) promotes colorectal cancer invasion by binding to PSF (also known as SFPQ, splicing factor proline and glutamine rich) and NONO (non-POU-domain-containing, octamer binding) [<xref rid="R158" ref-type="bibr">158</xref>]. A further study found that PSF and NONO promote GAPLINC to influence cell invasion partly by increasing the expression of SNAI2 (snail family zinc finger 2), a member of the snail family of transcription factors, which promotes cell invasion, motility, and metastasis via inhibiting E-cadherin transcription and inducing EMT in several human cancers [<xref rid="R158" ref-type="bibr">158</xref>&#x02013;<xref rid="R161" ref-type="bibr">161</xref>]. However, how PSF and NONO bound with GAPLINC and how they activate GAPLINC-associated genes to promote invasion is still unknown.</p></sec></sec><sec id="s2"><title>CONCLUSION</title><p>Currently, studies on lncRNAs have gradually become one of the hottest topics in the field of RNA biology, and lncRNAs have emerged as a versatile regulator of key pathophysiological pathways. LncRNAs have broad applications in cancer diagnosis and treatment because most of the well-studied lncRNAs are correlated with a poor prognosis in patients. The abnormal expression of lncRNAs in cancers reminds us they may be the targets of tumor diagnosis and treatment. Studies also show that lncRNAs take part in regulating cancer chemotherapy sensitivity. For example, <italic>HOTAIR</italic> activates the PI3K/Akt pathway by inhibiting the expression of miR-126 and promotes the development of cisplatin resistance in gastric cancer [<xref rid="R162" ref-type="bibr">162</xref>], while <italic>HOTAIR</italic> decreases chemoresistance through the activation of Wnt/&#x003b2;-catenin signaling in ovarian cancer [<xref rid="R80" ref-type="bibr">80</xref>]. Other lncRNAs, such as <italic>Linc00152</italic> [<xref rid="R163" ref-type="bibr">163</xref>], <italic>MALAT1</italic> [<xref rid="R164" ref-type="bibr">164</xref>], <italic>UCA1</italic> [<xref rid="R165" ref-type="bibr">165</xref>, <xref rid="R166" ref-type="bibr">166</xref>] and <italic>lnc-ROR</italic> [<xref rid="R167" ref-type="bibr">167</xref>], are associated with chemotherapy sensitivity.</p><p>In addition, lncRNAs detected in the blood may represent prominent novel biomarkers for cancer diagnostics. For example, <italic>HOTAIR</italic> is detected in colorectal cancer and represents an effective negative prognostic biomarker for colorectal cancer in blood samples [<xref rid="R168" ref-type="bibr">168</xref>]. <italic>MALAT1</italic> is elevated in the whole blood of metastatic lung cancer patients [<xref rid="R169" ref-type="bibr">169</xref>], and <italic>HULC,</italic> detected in the blood, is also proposed as a diagnostic biomarker both for liver cancer and gastric cancer [<xref rid="R170" ref-type="bibr">170</xref>, <xref rid="R171" ref-type="bibr">171</xref>]. Studies that illuminate the molecular mechanism of the abnormal expression of lncRNAs in various cancers are helpful to improve the efficiency of clinical treatments and the diagnosis of cancer.</p><p>More and more lncRNAs, with a differential expression in tumors, are being discovered, and these lncRNAs are important regulators of genes during cell metastasis or act as regulators for other metastasis-relevant genes. Up to now, two major mechanisms have emerged for how lncRNAs regulate cancer metastasis, including (1) binding to functional proteins characteristically and then affecting the transcription of genes associated with metastasis and (2) acting as ceRNAs for miRNAs that target genes involved in metastasis regulation. There are three control modes for lncRNAs to bind to functional proteins, including (1) by regulating the localization of binding proteins, lncRNAs play a role in the chromatin and epigenetic modification and the transcription of metastasis-relevant genes, (2) lncRNAs enhance or attenuate protein stability by binding to them, and (3) lncRNAs mask or expose the modification motif to inactivate or activate the binding protein.</p><p>In summary, this review highlights the interactions between lncRNAs and their binding proteins and the mechanisms of their collaborative roles in cancer metastasis (Table <xref ref-type="table" rid="T1">1</xref>), which provides systematic information and an evaluation of the potential of lncRNAs as prospective novel therapeutic targets in cancer.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Summary of lncRNAs and their binding proteins as regulators of cancer metastasis</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Symbol</th><th align="center" valign="middle" rowspan="1" colspan="1">Interaction protein</th><th align="center" valign="middle" rowspan="1" colspan="1">Archetype</th><th align="center" valign="middle" rowspan="1" colspan="1">Mechanism</th><th align="center" valign="middle" rowspan="1" colspan="1">Cancer type</th><th align="center" valign="middle" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="5" align="left" valign="middle" colspan="1">HOTAIR</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Promote the transcription of ABL2, SNAIL et al.)</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R130" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress E-cadherin transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">OSCC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R133" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (SUZ12)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Suppress promoter methylation of PCDH10</td><td align="center" valign="middle" rowspan="1" colspan="1">GISTs</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R132" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>HOTAIR-miR34a&#x02192; HGF/C-Met/Snail pathway</td><td align="center" valign="middle" rowspan="1" colspan="1">Gastric cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R131" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2, LSD1</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R127" ref-type="bibr">127</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NBAT1</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Promote the transcription of DKK1</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R172" ref-type="bibr">172</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DANCR</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Suppress the transcription of TIMP 2/3</td><td align="center" valign="middle" rowspan="1" colspan="1">Prostate cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R173" ref-type="bibr">173</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LINC00511</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress p57 expression</td><td align="center" valign="middle" rowspan="1" colspan="1">NSCLC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R134" ref-type="bibr">134</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Linc-UBC1</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2, SUZ12)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification</td><td align="center" valign="middle" rowspan="1" colspan="1">Bladder cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R174" ref-type="bibr">174</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LncRNA-EBIC</td><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress E-cadherin transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">Cervical cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R175" ref-type="bibr">175</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HOXA11-AS</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2, LSD1 or DNMT1</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold,<break/>decoy</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone/DNA modification<break/>&#x0201c;Sponge&#x0201d; of miR-1297</td><td align="center" valign="middle" rowspan="1" colspan="1">Gastric cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R134" ref-type="bibr">134</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LncRNA-GIHCG</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2, DNMT1</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone/DNA modification;<break/>Silence the expression of miR200 b/a/429</td><td align="center" valign="middle" rowspan="1" colspan="1">HCC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R135" ref-type="bibr">135</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AGAP2-AS1</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2, LSD1</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress LATS2 and KLF2 transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">NSCLC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R136" ref-type="bibr">136</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SChLAP1</td><td align="center" valign="middle" rowspan="1" colspan="1">SWI/SNF (SNF5)</td><td align="center" valign="middle" rowspan="1" colspan="1">Decoy</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;</td><td align="center" valign="middle" rowspan="1" colspan="1">Prostate cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R123" ref-type="bibr">123</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GClnc1</td><td align="center" valign="middle" rowspan="1" colspan="1">WDR5, KAT2A</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Promotes SOD2 transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">Gastric cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R106" ref-type="bibr">106</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZEB1-AS1</td><td align="center" valign="middle" rowspan="1" colspan="1">p300</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Activates ZEB1 transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">Osteosarcoma</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R142" ref-type="bibr">142</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SLNCR1</td><td align="center" valign="middle" rowspan="1" colspan="1">Bm3a, AR</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Activates MMP9 transcription</td><td align="center" valign="middle" rowspan="1" colspan="1">melanoma</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R143" ref-type="bibr">143</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BCAR4</td><td align="center" valign="middle" rowspan="1" colspan="1">SNIP1, PNUTS</td><td align="center" valign="middle" rowspan="1" colspan="1">Scaffold</td><td align="center" valign="middle" rowspan="1" colspan="1">CCL21&#x02192;BCAR4&#x02192;non-canonical Hedgehog/GLI2 pathway</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R144" ref-type="bibr">144</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LINC01133</td><td align="center" valign="middle" rowspan="1" colspan="1">SRSF6</td><td align="center" valign="middle" rowspan="1" colspan="1">Decoy</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R69" ref-type="bibr">69</xref>]</td></tr><tr><td rowspan="4" align="left" valign="middle" colspan="1">MALAT1</td><td align="center" valign="middle" rowspan="1" colspan="1">PSF</td><td align="center" valign="middle" rowspan="1" colspan="1">Decoy</td><td align="center" valign="middle" rowspan="1" colspan="1">Release oncogene PTBP2 from PSF/PTBP2 complex</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R145" ref-type="bibr">145</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide<break/>Decoy</td><td align="center" valign="middle" rowspan="1" colspan="1">Repress E-cadherin expression<break/>&#x0201c;Sponge&#x0201d; of miR-1297</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R176" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (EZH2)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress PCDH10 expression</td><td align="center" valign="middle" rowspan="1" colspan="1">Gastric cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R177" ref-type="bibr">177</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PRC2 (SUZ12)</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide<break/>Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress E-cadherin expression</td><td align="center" valign="middle" rowspan="1" colspan="1">Bladder cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R68" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TINCR</td><td align="center" valign="middle" rowspan="1" colspan="1">EpCAM</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">TINCR&#x02192; hydrolysis of EpCAM &#x02192; EpICD&#x02192;Wnt/&#x003b2;-catenin pathway</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R77" ref-type="bibr">77</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LncRNA-LET</td><td align="center" valign="middle" rowspan="1" colspan="1">NF90</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">LncRNA-LET&#x02192; NF90 degradation -HIF-1&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">HCC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R149" ref-type="bibr">149</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LncRNA-HIT</td><td align="center" valign="middle" rowspan="1" colspan="1">ZEB1</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">Protect ZEB1 from degradation and then Repress E-cadherin expression</td><td align="center" valign="middle" rowspan="1" colspan="1">NSCLC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R64" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AOC4P</td><td align="center" valign="middle" rowspan="1" colspan="1">Vimentin</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance vimentin degradation</td><td align="center" valign="middle" rowspan="1" colspan="1">HCC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R153" ref-type="bibr">153</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ANCR</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance the degradation of vimentin</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R178" ref-type="bibr">178</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NKILA</td><td align="center" valign="middle" rowspan="1" colspan="1">NF-&#x003ba;B/I&#x003ba;B</td><td align="center" valign="middle" rowspan="1" colspan="1">Signal</td><td align="center" valign="middle" rowspan="1" colspan="1">Blocks IkB phosphorylation</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R133" ref-type="bibr">133</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CCAT2</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress E-cadherin /LATS2 expression</td><td align="center" valign="middle" rowspan="1" colspan="1">Gastric cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R179" ref-type="bibr">179</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lnc TCF7</td><td align="center" valign="middle" rowspan="1" colspan="1">SWI/SNF</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Activate Wnt/&#x003b2;-catenin pathway</td><td align="center" valign="middle" rowspan="1" colspan="1">HCC</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R78" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HNF1A-AS1</td><td align="center" valign="middle" rowspan="1" colspan="1">DNMT1</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">DNA modification;<break/>Repress E-cadherin expression</td><td align="center" valign="middle" rowspan="1" colspan="1">Lung adenocarcinoma</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R180" ref-type="bibr">180</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HULC</td><td align="center" valign="middle" rowspan="1" colspan="1">EZH2</td><td align="center" valign="middle" rowspan="1" colspan="1">Guide</td><td align="center" valign="middle" rowspan="1" colspan="1">Histone modification;<break/>Repress NKD2 expression</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal cancer</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R181" ref-type="bibr">181</xref>]</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="con"><p><bold>Authors&#x02019; contributions</bold></p><p>FX, WX and ZZ designed and revised the manuscript. LY wrote the manuscript and drew figures. YT, YH, FW and SZ collected and related paper and created the table. CG, BX, MZ, NX, XL, YL and GL participated in the design and revise the review. All the authors read and approved the final version of the review.</p></fn><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn fn-type="supported-by"><p><bold>FUNDING</bold></p><p>This study was supported in part by grants from the National Natural Science Foundation of China (81372907, 81472531, 81572787, 81672683, 81672993, 81772928 and 81702907), the Program of Introducing Talents of Discipline to Universities (111-2-12), the Natural Science Foundation of Hunan Province (2015JJ1022, 2016JC2035 and 2017SK2105).</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>EMT</term><def><p>epithelial-mesenchymal transition</p></def></def-item><def-item><term>MET</term><def><p>mesenchymal-epithelial transition</p></def></def-item><def-item><term>lncRNAs</term><def><p>long non-coding RNAs</p></def></def-item><def-item><term>HOTAIR</term><def><p>HOX transcript antisense RNA</p></def></def-item><def-item><term>Xist</term><def><p>X-inactive-specific-transcript</p></def></def-item><def-item><term>CeRNAs</term><def><p>competing endogenous RNA</p></def></def-item><def-item><term>MREs</term><def><p>miRNAs responses elements</p></def></def-item><def-item><term>MALAT1</term><def><p>metastasis associated lung adenocarcinoma transcript 1</p></def></def-item><def-item><term>UCA1</term><def><p>urothelial cancer associated 1</p></def></def-item><def-item><term>HULC</term><def><p>hepatocellular carcinoma up-regulated long non-coding RNA</p></def></def-item><def-item><term>NEAT1</term><def><p>nuclear paraspeckle assembly transcript 1</p></def></def-item><def-item><term>SNHG1</term><def><p>small nucleolar RNA host gene 1</p></def></def-item><def-item><term>SCHLAP1</term><def><p>SWI/SNF complex antagonist associated with prostate cancer 1</p></def></def-item><def-item><term>ANRIL</term><def><p>CDKN2B antisense RNA 1</p></def></def-item><def-item><term>GClnc1</term><def><p>gastric cancer-associated lncRNA 1</p></def></def-item><def-item><term>SOD2</term><def><p>dismutase 2 mitochondrial)</p></def></def-item><def-item><term>HATs</term><def><p>histone acetyltransferases</p></def></def-item><def-item><term>SLNCR</term><def><p>SRA-like non-coding RNA</p></def></def-item><def-item><term>BCAR4</term><def><p>breast cancer anti-estrogen resistance 4</p></def></def-item><def-item><term>SNIP1</term><def><p>SMAD nuclear interacting protein 1</p></def></def-item><def-item><term>SRSF6</term><def><p>serine and arginine rich splicing factor 6</p></def></def-item><def-item><term>PTBP2</term><def><p>polypyrimidine tract binding protein 2</p></def></def-item><def-item><term>TINCR</term><def><p>Terminal differentiation-induced lncRNA</p></def></def-item><def-item><term>HDAC3</term><def><p>histone deacetylase 3</p></def></def-item><def-item><term><italic>HIF-1&#x003b1;</italic></term><def><p>hypoxia-inducible factor 1 alpha subunit</p></def></def-item><def-item><term>LncRNA-HIT</term><def><p>HOXA transcript induced by TGF-&#x003b2;</p></def></def-item><def-item><term>NSCLC</term><def><p>non-small cell lung cancer</p></def></def-item><def-item><term>ZEB1</term><def><p>zinc finger E-box binding homeobox 1</p></def></def-item><def-item><term>AOC4P</term><def><p>amine oxidase, copper containing 4, pseudogene</p></def></def-item><def-item><term>NKILA</term><def><p>NF-KappaB Interacting LncRNA</p></def></def-item><def-item><term>IkB</term><def><p>inhibitor of NF-kB</p></def></def-item><def-item><term>GAPLINC</term><def><p>Gastric adenocarcinoma predictive long inergenic noncoding RNA</p></def></def-item><def-item><term>SNAI2</term><def><p>snail family zinc finger 2</p></def></def-item><def-item><term>OSCC</term><def><p>oral squamous cell carcinoma</p></def></def-item><def-item><term>GISTs</term><def><p>gastrointestinal stromal tumors</p></def></def-item><def-item><term>HNF1A-AS1</term><def><p>lncRNA HNF1A-antisense 1</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanahan</surname><given-names>D</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><fpage>646</fpage><lpage>74</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2011.02.013">https://doi.org/10.1016/j.cell.2011.02.013</ext-link></comment><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Dikshit</surname><given-names>R</given-names></name><name name-style="western"><surname>Eser</surname><given-names>S</given-names></name><name name-style="western"><surname>Mathers</surname><given-names>C</given-names></name><name name-style="western"><surname>Rebelo</surname><given-names>M</given-names></name><name name-style="western"><surname>Parkin</surname><given-names>DM</given-names></name><name name-style="western"><surname>Forman</surname><given-names>D</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name></person-group><article-title>Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title><source>Int J Cancer</source><year>2015</year><volume>136</volume><fpage>E359</fpage><lpage>86</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.29210">https://doi.org/10.1002/ijc.29210</ext-link></comment><pub-id pub-id-type="pmid">25220842</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Wan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>LY</given-names></name><name name-style="western"><surname>Xie</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>HC</given-names></name><name name-style="western"><surname>Qin</surname><given-names>LX</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Ren</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Li</surname><given-names>YX</given-names></name><name name-style="western"><surname>Fan</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>WZ</given-names></name></person-group><article-title>miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma</article-title><source>J Exp Med</source><year>2013</year><volume>210</volume><fpage>789</fpage><lpage>803</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20120153">https://doi.org/10.1084/jem.20120153</ext-link></comment><pub-id pub-id-type="pmid">23478189</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutschner</surname><given-names>T</given-names></name><name name-style="western"><surname>Diederichs</surname><given-names>S</given-names></name></person-group><article-title>The hallmarks of cancer: a long non-coding RNA point of view</article-title><source>RNA Biol</source><year>2012</year><volume>9</volume><fpage>703</fpage><lpage>19</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4161/rna.20481">https://doi.org/10.4161/rna.20481</ext-link></comment><pub-id pub-id-type="pmid">22664915</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Qian</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shen</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus</article-title><source>Genet Med</source><year>2006</year><volume>8</volume><fpage>156</fpage><lpage>60</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.gim.0000196821.87655.d0">https://doi.org/10.1097/01.gim.0000196821.87655.d0</ext-link></comment><pub-id pub-id-type="pmid">16540749</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways</article-title><source>Mol Immunol</source><year>2007</year><volume>44</volume><fpage>984</fpage><lpage>92</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molimm.2006.03.013">https://doi.org/10.1016/j.molimm.2006.03.013</ext-link></comment><pub-id pub-id-type="pmid">16675017</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray</article-title><source>J Cancer Res Clin Oncol</source><year>2007</year><volume>133</volume><fpage>71</fpage><lpage>81</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00432-006-0136-2">https://doi.org/10.1007/s00432-006-0136-2</ext-link></comment><pub-id pub-id-type="pmid">16941191</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>YH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>WL</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Fan</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Li</surname><given-names>XL</given-names></name><name name-style="western"><surname>Luo</surname><given-names>XM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>MH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YX</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Qian</surname><given-names>J</given-names></name><etal/></person-group><article-title>Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway</article-title><source>Hum Pathol</source><year>2007</year><volume>38</volume><fpage>120</fpage><lpage>33</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.humpath.2006.06.023">https://doi.org/10.1016/j.humpath.2006.06.023</ext-link></comment><pub-id pub-id-type="pmid">16996564</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yi</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway</article-title><source>Int J Cancer</source><year>2008</year><volume>123</volume><fpage>2065</fpage><lpage>72</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.23727">https://doi.org/10.1002/ijc.23727</ext-link></comment><pub-id pub-id-type="pmid">18697201</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiery</surname><given-names>JP</given-names></name><name name-style="western"><surname>Acloque</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>RY</given-names></name><name name-style="western"><surname>Nieto</surname><given-names>MA</given-names></name></person-group><article-title>Epithelial-mesenchymal transitions in development and disease</article-title><source>Cell</source><year>2009</year><volume>139</volume><fpage>871</fpage><lpage>90</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2009.11.007">https://doi.org/10.1016/j.cell.2009.11.007</ext-link></comment><pub-id pub-id-type="pmid">19945376</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>36783</fpage><lpage>99</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.9170">https://doi.org/10.18632/oncotarget.9170</ext-link></comment><pub-id pub-id-type="pmid">27167345</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>K</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Tu</surname><given-names>C</given-names></name><name name-style="western"><surname>Qi</surname><given-names>P</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name></person-group><article-title>Genome-wide analysis of epstein-barr virus (EBV) integration and strain in C666-1 and raji cells</article-title><source>J Cancer</source><year>2016</year><volume>7</volume><fpage>214</fpage><lpage>24</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.13150">https://doi.org/10.7150/jca.13150</ext-link></comment><pub-id pub-id-type="pmid">26819646</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Tan</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma</article-title><source>Clin Transl Oncol</source><year>2016</year><volume>18</volume><fpage>206</fpage><lpage>11</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12094-015-1354-3">https://doi.org/10.1007/s12094-015-1354-3</ext-link></comment><pub-id pub-id-type="pmid">26260913</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fan</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><etal/></person-group><article-title>Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>39001</fpage><lpage>11</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.16545">https://doi.org/10.18632/oncotarget.16545</ext-link></comment><pub-id pub-id-type="pmid">28380458</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Cao</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>Role of tumor microenvironment in tumorigenesis</article-title><source>J Cancer</source><year>2017</year><volume>8</volume><fpage>761</fpage><lpage>73</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.17648">https://doi.org/10.7150/jca.17648</ext-link></comment><pub-id pub-id-type="pmid">28382138</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>CD</given-names></name><name name-style="western"><surname>Anyiwe</surname><given-names>K</given-names></name><name name-style="western"><surname>Schimmer</surname><given-names>AD</given-names></name></person-group><article-title>Anoikis resistance and tumor metastasis</article-title><source>Cancer Lett</source><year>2008</year><volume>272</volume><fpage>177</fpage><lpage>85</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2008.05.029">https://doi.org/10.1016/j.canlet.2008.05.029</ext-link></comment><pub-id pub-id-type="pmid">18579285</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Circular RNAs in human cancer</article-title><source>Mol Cancer</source><year>2017</year><volume>16</volume><fpage>25</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12943-017-0598-7">https://doi.org/10.1186/s12943-017-0598-7</ext-link></comment><pub-id pub-id-type="pmid">28143578</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xue</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T</given-names></name></person-group><article-title>The long noncoding RNA MALAT-1 is a novel biomarker in various cancers: a meta-analysis based on the geo database and literature</article-title><source>J Cancer</source><year>2016</year><volume>7</volume><fpage>991</fpage><lpage>1001</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.14663">https://doi.org/10.7150/jca.14663</ext-link></comment><pub-id pub-id-type="pmid">27313790</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Long non-coding RNAs in cancer</article-title><source>Sci China Life Sci</source><year>2012</year><volume>55</volume><fpage>1120</fpage><lpage>24</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11427-012-4413-9">https://doi.org/10.1007/s11427-012-4413-9</ext-link></comment><pub-id pub-id-type="pmid">23233227</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma</article-title><source>J Cancer</source><year>2017</year><volume>8</volume><fpage>97</fpage><lpage>103</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.16819">https://doi.org/10.7150/jca.16819</ext-link></comment><pub-id pub-id-type="pmid">28123602</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>16621</fpage><lpage>32</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.14200">https://doi.org/10.18632/oncotarget.14200</ext-link></comment><pub-id pub-id-type="pmid">28039470</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma</article-title><source>J Cancer</source><year>2017</year><volume>8</volume><fpage>523</fpage><lpage>30</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.17510">https://doi.org/10.7150/jca.17510</ext-link></comment><pub-id pub-id-type="pmid">28367232</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prensner</surname><given-names>JR</given-names></name><name name-style="western"><surname>Chinnaiyan</surname><given-names>AM</given-names></name></person-group><article-title>The emergence of lncRNAs in cancer biology</article-title><source>Cancer Discov</source><year>2011</year><volume>1</volume><fpage>391</fpage><lpage>407</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/2159-8290.CD-11-0209">https://doi.org/10.1158/2159-8290.CD-11-0209</ext-link></comment><pub-id pub-id-type="pmid">22096659</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niland</surname><given-names>CN</given-names></name><name name-style="western"><surname>Merry</surname><given-names>CR</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>AM</given-names></name></person-group><article-title>Emerging roles for long non-coding RNAs in cancer and neurological disorders</article-title><source>Front Genet</source><year>2012</year><volume>3</volume><fpage>25</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2012.00025">https://doi.org/10.3389/fgene.2012.00025</ext-link></comment><pub-id pub-id-type="pmid">22375145</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Insight into the role of long noncoding RNA in cancer development and progression</article-title><source>Int Rev Cell Mol Biol</source><year>2016</year><volume>326</volume><fpage>33</fpage><lpage>65</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/bs.ircmb.2016.04.001">https://doi.org/10.1016/bs.ircmb.2016.04.001</ext-link></comment><pub-id pub-id-type="pmid">27572126</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>HYOU1, regulated by LPLUNC1, is up-regulated in nasopharyngeal carcinoma and associated with poor prognosis</article-title><source>J Cancer</source><year>2016</year><volume>7</volume><fpage>367</fpage><lpage>76</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7150/jca.13695">https://doi.org/10.7150/jca.13695</ext-link></comment><pub-id pub-id-type="pmid">26918051</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fan</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name></person-group><article-title>Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer</article-title><source>Mol Cancer</source><year>2017</year><volume>16</volume><fpage>42</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12943-017-0612-0">https://doi.org/10.1186/s12943-017-0612-0</ext-link></comment><pub-id pub-id-type="pmid">28212646</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>C</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qi</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genome-wide analysis of eighteen epstein-barr viruses isolated from primary nasopharyngeal carcinoma biopsies</article-title><source>J Virol</source><year>2017</year><volume>91</volume><fpage>e00301</fpage><lpage>17</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00301-17">https://doi.org/10.1128/JVI.00301-17</ext-link></comment><pub-id pub-id-type="pmid">28637758</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>C</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Role of long non-coding RNAs in glucose metabolism in cancer</article-title><source>Mol Cancer</source><year>2017</year><volume>16</volume><fpage>130</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12943-017-0699-3">https://doi.org/10.1186/s12943-017-0699-3</ext-link></comment><pub-id pub-id-type="pmid">28738810</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Yi</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Nasopharyngeal carcinoma: advances in genomics and molecular genetics</article-title><source>Sci China Life Sci</source><year>2011</year><volume>54</volume><fpage>966</fpage><lpage>75</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11427-011-4223-5">https://doi.org/10.1007/s11427-011-4223-5</ext-link></comment><pub-id pub-id-type="pmid">22038010</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Deng</surname><given-names>M</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis</article-title><source>Eur J Cancer Prev</source><year>2013</year><volume>22</volume><fpage>68</fpage><lpage>76</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/CEJ.0b013e328354d351">https://doi.org/10.1097/CEJ.0b013e328354d351</ext-link></comment><pub-id pub-id-type="pmid">22728421</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Peng</surname><given-names>S</given-names></name><etal/></person-group><article-title>LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e62869</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0062869">https://doi.org/10.1371/journal.pone.0062869</ext-link></comment><pub-id pub-id-type="pmid">23650533</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><etal/></person-group><article-title>LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation</article-title><source>Oncogene</source><year>2014</year><volume>33</volume><fpage>2098</fpage><lpage>109</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2013.161">https://doi.org/10.1038/onc.2013.161</ext-link></comment><pub-id pub-id-type="pmid">23708661</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Bo</surname><given-names>H</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas</article-title><source>Sci China Life Sci</source><year>2014</year><volume>57</volume><fpage>315</fpage><lpage>26</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11427-013-4577-y">https://doi.org/10.1007/s11427-013-4577-y</ext-link></comment><pub-id pub-id-type="pmid">24532457</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>DC</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group><article-title>SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells</article-title><source>FEBS J</source><year>2014</year><volume>281</volume><fpage>4815</fpage><lpage>29</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/febs.13020">https://doi.org/10.1111/febs.13020</ext-link></comment><pub-id pub-id-type="pmid">25161098</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Zou</surname><given-names>G</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Tan</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma</article-title><source>Tumour Biol</source><year>2015</year><volume>36</volume><fpage>675</fpage><lpage>83</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-014-2650-1">https://doi.org/10.1007/s13277-014-2650-1</ext-link></comment><pub-id pub-id-type="pmid">25286756</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JM</given-names></name><name name-style="western"><surname>Dedhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EW</given-names></name></person-group><article-title>The epithelial-mesenchymal transition: new insights in signaling, development, and disease</article-title><source>J Cell Biol</source><year>2006</year><volume>172</volume><fpage>973</fpage><lpage>81</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1083/jcb.200601018">https://doi.org/10.1083/jcb.200601018</ext-link></comment><pub-id pub-id-type="pmid">16567498</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Evaluation of the prognostic value of TGF-&#x003b2; superfamily type I receptor and TGF-&#x003b2; type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays</article-title><source>J Mol Histol</source><year>2012</year><volume>43</volume><fpage>297</fpage><lpage>306</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10735-012-9392-4">https://doi.org/10.1007/s10735-012-9392-4</ext-link></comment><pub-id pub-id-type="pmid">22391627</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>12503</fpage><lpage>12</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-016-5113-z">https://doi.org/10.1007/s13277-016-5113-z</ext-link></comment><pub-id pub-id-type="pmid">27337956</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name></person-group><article-title>TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer</article-title><source>Int J Oncol</source><year>2016</year><volume>49</volume><fpage>1046</fpage><lpage>56</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/ijo.2016.3599">https://doi.org/10.3892/ijo.2016.3599</ext-link></comment><pub-id pub-id-type="pmid">27573352</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name></person-group><article-title>Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network</article-title><source>Mol Cell Biochem</source><year>2016</year><volume>411</volume><fpage>57</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11010-015-2568-y">https://doi.org/10.1007/s11010-015-2568-y</ext-link></comment><pub-id pub-id-type="pmid">26407966</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>The basics of epithelial-mesenchymal transition</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><fpage>1420</fpage><lpage>28</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI39104">https://doi.org/10.1172/JCI39104</ext-link></comment><pub-id pub-id-type="pmid">19487818</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nieto</surname><given-names>MA</given-names></name></person-group><article-title>The ins and outs of the epithelial to mesenchymal transition in health and disease</article-title><source>Annu Rev Cell Dev Biol</source><year>2011</year><volume>27</volume><fpage>347</fpage><lpage>76</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-cellbio-092910-154036">https://doi.org/10.1146/annurev-cellbio-092910-154036</ext-link></comment><pub-id pub-id-type="pmid">21740232</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goswami</surname><given-names>MT</given-names></name><name name-style="western"><surname>Reka</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kurapati</surname><given-names>H</given-names></name><name name-style="western"><surname>Kaza</surname><given-names>V</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Standiford</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Keshamouni</surname><given-names>VG</given-names></name></person-group><article-title>Regulation of complement-dependent cytotoxicity by TGF-&#x003b2;-induced epithelial-mesenchymal transition</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>1888</fpage><lpage>98</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2015.258">https://doi.org/10.1038/onc.2015.258</ext-link></comment><pub-id pub-id-type="pmid">26148233</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tse</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></name></person-group><article-title>Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment</article-title><source>J Cell Biochem</source><year>2007</year><volume>101</volume><fpage>816</fpage><lpage>29</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcb.21215">https://doi.org/10.1002/jcb.21215</ext-link></comment><pub-id pub-id-type="pmid">17243120</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>M</given-names></name><name name-style="western"><surname>Ann</surname><given-names>DK</given-names></name><name name-style="western"><surname>Han</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>C</given-names></name><name name-style="western"><surname>Flodby</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Q</given-names></name><name name-style="western"><surname>Krishnaveni</surname><given-names>MS</given-names></name><name name-style="western"><surname>Liebler</surname><given-names>JM</given-names></name><name name-style="western"><surname>Minoo</surname><given-names>P</given-names></name><name name-style="western"><surname>Crandall</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Interactions between &#x003b2;-catenin and transforming growth factor-&#x003b2; signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>7026</fpage><lpage>38</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M111.276311">https://doi.org/10.1074/jbc.M111.276311</ext-link></comment><pub-id pub-id-type="pmid">22241478</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiery</surname><given-names>JP</given-names></name></person-group><article-title>Epithelial-mesenchymal transitions in development and pathologies</article-title><source>Curr Opin Cell Biol</source><year>2003</year><volume>15</volume><fpage>740</fpage><lpage>46</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ceb.2003.10.006">https://doi.org/10.1016/j.ceb.2003.10.006</ext-link></comment><pub-id pub-id-type="pmid">14644200</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><name name-style="western"><surname>Weng</surname><given-names>X</given-names></name><name name-style="western"><surname>Yi</surname><given-names>W</given-names></name><name name-style="western"><surname>Bode</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>AID expression increased by TNF-&#x003b1; is associated with class switch recombination of Ig&#x003b1; gene in cancers</article-title><source>Cell Mol Immunol</source><year>2016</year><volume>13</volume><fpage>484</fpage><lpage>91</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2015.26">https://doi.org/10.1038/cmi.2015.26</ext-link></comment><pub-id pub-id-type="pmid">25849121</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Hu</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Bode</surname><given-names>AM</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Activation of the Ig I&#x003b1;1 promoter by the transcription factor Ets-1 triggers Ig I&#x003b1;1-C&#x003b1;1 germline transcription in epithelial cancer cells</article-title><source>Cell Mol Immunol</source><year>2014</year><volume>11</volume><fpage>197</fpage><lpage>205</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2013.52">https://doi.org/10.1038/cmi.2013.52</ext-link></comment><pub-id pub-id-type="pmid">24185710</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>D</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Bode</surname><given-names>AM</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Heterogeneity of aberrant immunoglobulin expression in cancer cells</article-title><source>Cell Mol Immunol</source><year>2011</year><volume>8</volume><fpage>479</fpage><lpage>85</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2011.25">https://doi.org/10.1038/cmi.2011.25</ext-link></comment><pub-id pub-id-type="pmid">21860405</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ren</surname><given-names>W</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Immunoglobulin expression and its biological significance in cancer cells</article-title><source>Cell Mol Immunol</source><year>2008</year><volume>5</volume><fpage>319</fpage><lpage>24</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2008.39">https://doi.org/10.1038/cmi.2008.39</ext-link></comment><pub-id pub-id-type="pmid">18954554</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>D</given-names></name><name name-style="western"><surname>Bode</surname><given-names>A</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines</article-title><source>Cell Mol Immunol</source><year>2012</year><volume>9</volume><fpage>54</fpage><lpage>61</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2011.40">https://doi.org/10.1038/cmi.2011.40</ext-link></comment><pub-id pub-id-type="pmid">22036905</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Niu</surname><given-names>W</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>JB</given-names></name><name name-style="western"><surname>Tan</surname><given-names>M</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-&#x0043a;B signaling pathway</article-title><source>Cell Mol Immunol</source><year>2017</year><volume>14</volume><fpage>830</fpage><lpage>841</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cmi.2016.31PMID:27374794">https://doi.org/10.1038/cmi.2016.31 PMID:27374794</ext-link></comment></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W</given-names></name><name name-style="western"><surname>He</surname><given-names>W</given-names></name><name name-style="western"><surname>Deng</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Inhibition of Epstein-Barr virus infection by lactoferrin</article-title><source>J Innate Immun</source><year>2012</year><volume>4</volume><fpage>387</fpage><lpage>98</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000336178">https://doi.org/10.1159/000336178</ext-link></comment><pub-id pub-id-type="pmid">22433582</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yi</surname><given-names>W</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways</article-title><source>J Med Virol</source><year>2007</year><volume>79</volume><fpage>1153</fpage><lpage>63</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jmv.20896">https://doi.org/10.1002/jmv.20896</ext-link></comment><pub-id pub-id-type="pmid">17597480</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>L</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells</article-title><source>J Virol</source><year>2012</year><volume>86</volume><fpage>3088</fpage><lpage>99</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.05901-11">https://doi.org/10.1128/JVI.05901-11</ext-link></comment><pub-id pub-id-type="pmid">22205737</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>A precise excision of the complete Epstein-Barr virus genome in a plasmid based on a bacterial artificial chromosome</article-title><source>J Virol Methods</source><year>2011</year><volume>176</volume><fpage>103</fpage><lpage>07</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jviromet.2011.06.015">https://doi.org/10.1016/j.jviromet.2011.06.015</ext-link></comment><pub-id pub-id-type="pmid">21723326</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ren</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>HD</given-names></name><name name-style="western"><surname>Hu</surname><given-names>D</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>J</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells</article-title><source>Mol Immunol</source><year>2007</year><volume>44</volume><fpage>2221</fpage><lpage>27</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molimm.2006.11.010">https://doi.org/10.1016/j.molimm.2006.11.010</ext-link></comment><pub-id pub-id-type="pmid">17174398</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>YH</given-names></name><name name-style="western"><surname>Hu</surname><given-names>JY</given-names></name><name name-style="western"><surname>Li</surname><given-names>GC</given-names></name></person-group><article-title>Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>2769</fpage><lpage>74</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2010.01.033">https://doi.org/10.1016/j.vaccine.2010.01.033</ext-link></comment><pub-id pub-id-type="pmid">20117260</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>M</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Yi</surname><given-names>W</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1</article-title><source>Virus Res</source><year>2007</year><volume>130</volume><fpage>275</fpage><lpage>80</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2007.05.013">https://doi.org/10.1016/j.virusres.2007.05.013</ext-link></comment><pub-id pub-id-type="pmid">17576019</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moustakas</surname><given-names>A</given-names></name><name name-style="western"><surname>Heldin</surname><given-names>CH</given-names></name></person-group><article-title>Mechanisms of TGFbeta-induced epithelial-mesenchymal transition</article-title><source>J Clin Med</source><year>2016</year><volume>5</volume><fpage>E63</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/jcm5070063">https://doi.org/10.3390/jcm5070063</ext-link></comment><pub-id pub-id-type="pmid">27367735</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moustakas</surname><given-names>A</given-names></name><name name-style="western"><surname>Heldin</surname><given-names>P</given-names></name></person-group><article-title>TGF&#x003b2; and matrix-regulated epithelial to mesenchymal transition</article-title><source>Biochim Biophys Acta</source><year>2014</year><volume>1840</volume><fpage>2621</fpage><lpage>34</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbagen.2014.02.004">https://doi.org/10.1016/j.bbagen.2014.02.004</ext-link></comment><pub-id pub-id-type="pmid">24561266</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Li</surname><given-names>ZP</given-names></name><name name-style="western"><surname>Permuth-Wey</surname><given-names>J</given-names></name><name name-style="western"><surname>Challa</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kong</surname><given-names>W</given-names></name><name name-style="western"><surname>Dan</surname><given-names>S</given-names></name><name name-style="western"><surname>Bui</surname><given-names>MM</given-names></name><name name-style="western"><surname>Coppola</surname><given-names>D</given-names></name><name name-style="western"><surname>Mao</surname><given-names>WM</given-names></name><name name-style="western"><surname>Sellers</surname><given-names>TA</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>JQ</given-names></name></person-group><article-title>Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) &#x003b2;: LncRNA-hit-mediated TGF&#x003b2;-induced epithelial to mesenchymal transition in mammary epithelia</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>6857</fpage><lpage>67</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M114.610915">https://doi.org/10.1074/jbc.M114.610915</ext-link></comment><pub-id pub-id-type="pmid">25605728</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>Upregulation of LncRNA-HIT promotes migration and invasion of non-small cell lung cancer cells by association with ZEB1</article-title><source>Cancer Med</source><year>2016</year><volume>5</volume><fpage>3555</fpage><lpage>63</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cam4.948">https://doi.org/10.1002/cam4.948</ext-link></comment><pub-id pub-id-type="pmid">27790864</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>JH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ma</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Guo</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Tao</surname><given-names>QF</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TT</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>CC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YZ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A long noncoding RNA activated by TGF-&#x003b2; promotes the invasion-metastasis cascade in hepatocellular carcinoma</article-title><source>Cancer Cell</source><year>2014</year><volume>25</volume><fpage>666</fpage><lpage>81</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccr.2014.03.010">https://doi.org/10.1016/j.ccr.2014.03.010</ext-link></comment><pub-id pub-id-type="pmid">24768205</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>B</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name></person-group><article-title>LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis</article-title><source>J Gastroenterol Hepatol</source><year>2016</year><volume>31</volume><fpage>595</fpage><lpage>603</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jgh.13206">https://doi.org/10.1111/jgh.13206</ext-link></comment><pub-id pub-id-type="pmid">26487301</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Shen</surname><given-names>B</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name></person-group><article-title>TGF&#x003b2;1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>11924</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep11924">https://doi.org/10.1038/srep11924</ext-link></comment><pub-id pub-id-type="pmid">26152796</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>B</given-names></name><name name-style="western"><surname>Tan</surname><given-names>M</given-names></name><name name-style="western"><surname>Mu</surname><given-names>X</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>TGF-&#x003b2;-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12</article-title><source>Clin Cancer Res</source><year>2014</year><volume>20</volume><fpage>1531</fpage><lpage>41</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-13-1455">https://doi.org/10.1158/1078-0432.CCR-13-1455</ext-link></comment><pub-id pub-id-type="pmid">24449823</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Wan</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M</given-names></name></person-group><article-title>Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6</article-title><source>Cancer Lett</source><year>2016</year><volume>380</volume><fpage>476</fpage><lpage>84</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2016.07.015">https://doi.org/10.1016/j.canlet.2016.07.015</ext-link></comment><pub-id pub-id-type="pmid">27443606</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Han</surname><given-names>L</given-names></name><name name-style="western"><surname>Pu</surname><given-names>P</given-names></name><name name-style="western"><surname>Kang</surname><given-names>C</given-names></name></person-group><article-title>Wnt/beta-catenin signaling in glioma</article-title><source>J Neuroimmune Pharmacol</source><year>2012</year><volume>7</volume><fpage>740</fpage><lpage>49</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11481-012-9359-y">https://doi.org/10.1007/s11481-012-9359-y</ext-link></comment><pub-id pub-id-type="pmid">22454041</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashihara</surname><given-names>E</given-names></name><name name-style="western"><surname>Takada</surname><given-names>T</given-names></name><name name-style="western"><surname>Maekawa</surname><given-names>T</given-names></name></person-group><article-title>Targeting the canonical Wnt/&#x003b2;-catenin pathway in hematological malignancies</article-title><source>Cancer Sci</source><year>2015</year><volume>106</volume><fpage>665</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cas.12655">https://doi.org/10.1111/cas.12655</ext-link></comment><pub-id pub-id-type="pmid">25788321</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name></person-group><article-title>The crosstalk between microRNAs and the Wnt/&#x003b2;-catenin signaling pathway in cancer</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>14089</fpage><lpage>106</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.12923">https://doi.org/10.18632/oncotarget.12923</ext-link></comment><pub-id pub-id-type="pmid">27793042</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pai</surname><given-names>SG</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mota</surname><given-names>JM</given-names></name><name name-style="western"><surname>Costa</surname><given-names>R</given-names></name><name name-style="western"><surname>Leite</surname><given-names>CA</given-names></name><name name-style="western"><surname>Barroso-Sousa</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>JB</given-names></name><name name-style="western"><surname>Chae</surname><given-names>YK</given-names></name><name name-style="western"><surname>Giles</surname><given-names>FJ</given-names></name></person-group><article-title>Wnt/beta-catenin pathway: modulating anticancer immune response</article-title><source>J Hematol Oncol</source><year>2017</year><volume>10</volume><fpage>101</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13045-017-0471-6">https://doi.org/10.1186/s13045-017-0471-6</ext-link></comment><pub-id pub-id-type="pmid">28476164</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>XS</given-names></name><name name-style="western"><surname>Ma</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>XH</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>HL</given-names></name><name name-style="western"><surname>Liao</surname><given-names>XY</given-names></name><name name-style="western"><surname>Xue</surname><given-names>WQ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YB</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jia</surname><given-names>WH</given-names></name></person-group><article-title>HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway</article-title><source>Cancer Sci</source><year>2013</year><volume>104</volume><fpage>1675</fpage><lpage>82</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cas.12296">https://doi.org/10.1111/cas.12296</ext-link></comment><pub-id pub-id-type="pmid">24118380</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vassallo</surname><given-names>I</given-names></name><name name-style="western"><surname>Zinn</surname><given-names>P</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M</given-names></name><name name-style="western"><surname>Rajakannu</surname><given-names>P</given-names></name><name name-style="western"><surname>Hamou</surname><given-names>MF</given-names></name><name name-style="western"><surname>Hegi</surname><given-names>ME</given-names></name></person-group><article-title>WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>12</fpage><lpage>21</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2015.61">https://doi.org/10.1038/onc.2015.61</ext-link></comment><pub-id pub-id-type="pmid">25772239</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name></person-group><article-title>Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression</article-title><source>Cancer Lett</source><year>2013</year><volume>333</volume><fpage>213</fpage><lpage>21</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2013.01.033">https://doi.org/10.1016/j.canlet.2013.01.033</ext-link></comment><pub-id pub-id-type="pmid">23354591</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Lu</surname><given-names>YX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YY</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Hu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>XN</given-names></name></person-group><article-title>Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>22639</fpage><lpage>49</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.8141">https://doi.org/10.18632/oncotarget.8141</ext-link></comment><pub-id pub-id-type="pmid">27009809</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>P</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><name name-style="western"><surname>Ye</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><etal/></person-group><article-title>The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling</article-title><source>Cell Stem Cell</source><year>2015</year><volume>16</volume><fpage>413</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.stem.2015.03.003">https://doi.org/10.1016/j.stem.2015.03.003</ext-link></comment><pub-id pub-id-type="pmid">25842979</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>XS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XA</given-names></name><name name-style="western"><surname>Wu</surname><given-names>WG</given-names></name><name name-style="western"><surname>Hu</surname><given-names>YP</given-names></name><name name-style="western"><surname>Li</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name><name name-style="western"><surname>Weng</surname><given-names>H</given-names></name><name name-style="western"><surname>Shu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>TY</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bao</surname><given-names>RF</given-names></name><name name-style="western"><surname>Mu</surname><given-names>JS</given-names></name><etal/></person-group><article-title>MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway</article-title><source>Cancer Biol Ther</source><year>2014</year><volume>15</volume><fpage>806</fpage><lpage>14</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4161/cbt.28584">https://doi.org/10.4161/cbt.28584</ext-link></comment><pub-id pub-id-type="pmid">24658096</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Su</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name></person-group><article-title>Erratum to: overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/&#x003b2;-catenin pathway in human ovarian cancer</article-title><source>Tumour Biol</source><year>2015</year><volume>36</volume><fpage>9093</fpage><lpage>94</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-015-4210-8">https://doi.org/10.1007/s13277-015-4210-8</ext-link></comment><pub-id pub-id-type="pmid">26518770</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhi</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name></person-group><article-title>Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway</article-title><source>J Exp Clin Cancer Res</source><year>2015</year><volume>34</volume><fpage>135</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13046-015-0250-6">https://doi.org/10.1186/s13046-015-0250-6</ext-link></comment><pub-id pub-id-type="pmid">26538117</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Sui</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Bai</surname><given-names>N</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Pang</surname><given-names>D</given-names></name></person-group><article-title>Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer</article-title><source>Int J Clin Exp Pathol</source><year>2015</year><volume>8</volume><fpage>4881</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">26191181</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>G</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Gao</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name></person-group><article-title>MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway</article-title><source>Tumour Biol</source><year>2015</year><volume>36</volume><fpage>1477</fpage><lpage>86</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-014-2631-4">https://doi.org/10.1007/s13277-014-2631-4</ext-link></comment><pub-id pub-id-type="pmid">25431257</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YD</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Xue</surname><given-names>HZ</given-names></name></person-group><article-title>lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition</article-title><source>Hepatol Res</source><year>2016</year><volume>46</volume><fpage>1137</fpage><lpage>44</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/hepr.12659">https://doi.org/10.1111/hepr.12659</ext-link></comment><pub-id pub-id-type="pmid">27391793</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Audas</surname><given-names>TE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name></person-group><article-title>Stressing out over long noncoding RNA</article-title><source>Biochim Biophys Acta</source><year>2016</year><volume>1859</volume><fpage>184</fpage><lpage>91</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbagrm.2015.06.010">https://doi.org/10.1016/j.bbagrm.2015.06.010</ext-link></comment><pub-id pub-id-type="pmid">26142536</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>L</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Fu</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>PC</given-names></name><name name-style="western"><surname>Xu</surname><given-names>WR</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression</article-title><source>J Cancer Res Clin Oncol</source><year>2017</year><volume>143</volume><fpage>991</fpage><lpage>1004</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00432-017-2361-2">https://doi.org/10.1007/s00432-017-2361-2</ext-link></comment><pub-id pub-id-type="pmid">28285404</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renganathan</surname><given-names>A</given-names></name><name name-style="western"><surname>Kresoja-Rakic</surname><given-names>J</given-names></name><name name-style="western"><surname>Echeverry</surname><given-names>N</given-names></name><name name-style="western"><surname>Ziltener</surname><given-names>G</given-names></name><name name-style="western"><surname>Vrugt</surname><given-names>B</given-names></name><name name-style="western"><surname>Opitz</surname><given-names>I</given-names></name><name name-style="western"><surname>Stahel</surname><given-names>RA</given-names></name><name name-style="western"><surname>Felley-Bosco</surname><given-names>E</given-names></name></person-group><article-title>GAS5 long non-coding RNA in malignant pleural mesothelioma</article-title><source>Mol Cancer</source><year>2014</year><volume>13</volume><fpage>119</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1476-4598-13-119">https://doi.org/10.1186/1476-4598-13-119</ext-link></comment><pub-id pub-id-type="pmid">24885398</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Tu</surname><given-names>G</given-names></name><name name-style="western"><surname>Du</surname><given-names>YE</given-names></name><name name-style="western"><surname>Wen</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name></person-group><article-title>LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway</article-title><source>Stem Cells</source><year>2016</year><volume>34</volume><fpage>55</fpage><lpage>66</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/stem.2219">https://doi.org/10.1002/stem.2219</ext-link></comment><pub-id pub-id-type="pmid">26418365</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mercer</surname><given-names>TR</given-names></name><name name-style="western"><surname>Mattick</surname><given-names>JS</given-names></name></person-group><article-title>Structure and function of long noncoding RNAs in epigenetic regulation</article-title><source>Nat Struct Mol Biol</source><year>2013</year><volume>20</volume><fpage>300</fpage><lpage>07</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nsmb.2480">https://doi.org/10.1038/nsmb.2480</ext-link></comment><pub-id pub-id-type="pmid">23463315</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>KC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Molecular mechanisms of long noncoding RNAs</article-title><source>Mol Cell</source><year>2011</year><volume>43</volume><fpage>904</fpage><lpage>14</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.08.018">https://doi.org/10.1016/j.molcel.2011.08.018</ext-link></comment><pub-id pub-id-type="pmid">21925379</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Guttman</surname><given-names>M</given-names></name><name name-style="western"><surname>Feldser</surname><given-names>D</given-names></name><name name-style="western"><surname>Garber</surname><given-names>M</given-names></name><name name-style="western"><surname>Koziol</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kenzelmann-Broz</surname><given-names>D</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>AM</given-names></name><name name-style="western"><surname>Zuk</surname><given-names>O</given-names></name><name name-style="western"><surname>Amit</surname><given-names>I</given-names></name><name name-style="western"><surname>Rabani</surname><given-names>M</given-names></name><name name-style="western"><surname>Attardi</surname><given-names>LD</given-names></name><name name-style="western"><surname>Regev</surname><given-names>A</given-names></name><name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name><etal/></person-group><article-title>A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response</article-title><source>Cell</source><year>2010</year><volume>142</volume><fpage>409</fpage><lpage>19</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2010.06.040">https://doi.org/10.1016/j.cell.2010.06.040</ext-link></comment><pub-id pub-id-type="pmid">20673990</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rinn</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kertesz</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JK</given-names></name><name name-style="western"><surname>Squazzo</surname><given-names>SL</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Brugmann</surname><given-names>SA</given-names></name><name name-style="western"><surname>Goodnough</surname><given-names>LH</given-names></name><name name-style="western"><surname>Helms</surname><given-names>JA</given-names></name><name name-style="western"><surname>Farnham</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Segal</surname><given-names>E</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs</article-title><source>Cell</source><year>2007</year><volume>129</volume><fpage>1311</fpage><lpage>23</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2007.05.022">https://doi.org/10.1016/j.cell.2007.05.022</ext-link></comment><pub-id pub-id-type="pmid">17604720</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>D</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JT</given-names></name></person-group><article-title>The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation</article-title><source>Cell</source><year>2010</year><volume>143</volume><fpage>390</fpage><lpage>403</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2010.09.049">https://doi.org/10.1016/j.cell.2010.09.049</ext-link></comment><pub-id pub-id-type="pmid">21029862</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name><name name-style="western"><surname>Poliseno</surname><given-names>L</given-names></name><name name-style="western"><surname>Tay</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kats</surname><given-names>L</given-names></name><name name-style="western"><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group><article-title>A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?</article-title><source>Cell</source><year>2011</year><volume>146</volume><fpage>353</fpage><lpage>58</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2011.07.014">https://doi.org/10.1016/j.cell.2011.07.014</ext-link></comment><pub-id pub-id-type="pmid">21802130</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen</surname><given-names>R</given-names></name><name name-style="western"><surname>Ghosal</surname><given-names>S</given-names></name><name name-style="western"><surname>Das</surname><given-names>S</given-names></name><name name-style="western"><surname>Balti</surname><given-names>S</given-names></name><name name-style="western"><surname>Chakrabarti</surname><given-names>J</given-names></name></person-group><article-title>Competing endogenous RNA: the key to posttranscriptional regulation</article-title><source>Sci World J</source><year>2014</year><volume>2014</volume><fpage>896206</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2014/896206">https://doi.org/10.1155/2014/896206</ext-link></comment></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ghazal</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><name name-style="western"><surname>Bellone</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Santin</surname><given-names>AD</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title>Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation</article-title><source>Oncogene</source><year>2015</year><volume>34</volume><fpage>3076</fpage><lpage>84</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2014.236">https://doi.org/10.1038/onc.2014.236</ext-link></comment><pub-id pub-id-type="pmid">25088204</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>C</given-names></name><name name-style="western"><surname>Nong</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ai</surname><given-names>K</given-names></name></person-group><article-title>H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT</article-title><source>Tumour Biol</source><year>2014</year><volume>35</volume><fpage>9163</fpage><lpage>69</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-014-2185-5">https://doi.org/10.1007/s13277-014-2185-5</ext-link></comment><pub-id pub-id-type="pmid">24920070</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name></person-group><article-title>H19 functions as a ceRNA in promoting metastasis through decreasing miR-200s activity in osteosarcoma</article-title><source>DNA Cell Biol</source><year>2016</year><volume>35</volume><fpage>235</fpage><lpage>40</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/dna.2015.3171">https://doi.org/10.1089/dna.2015.3171</ext-link></comment><pub-id pub-id-type="pmid">27008415</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name></person-group><article-title>Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma</article-title><source>Biochem Biophys Res Commun</source><year>2016</year><volume>473</volume><fpage>913</fpage><lpage>19</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2016.03.150">https://doi.org/10.1016/j.bbrc.2016.03.150</ext-link></comment><pub-id pub-id-type="pmid">27040767</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Qu</surname><given-names>H</given-names></name></person-group><article-title>Long non-coding RNA HOTAIR promotes HLA-G expression via inhibiting miR-152 in gastric cancer cells</article-title><source>Biochem Biophys Res Commun</source><year>2015</year><volume>464</volume><fpage>807</fpage><lpage>13</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbrc.2015.07.040">https://doi.org/10.1016/j.bbrc.2015.07.040</ext-link></comment><pub-id pub-id-type="pmid">26187665</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Nie</surname><given-names>FQ</given-names></name><name name-style="western"><surname>Ge</surname><given-names>YB</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>EB</given-names></name><name name-style="western"><surname>Yin</surname><given-names>DD</given-names></name><name name-style="western"><surname>Kong</surname><given-names>R</given-names></name><name name-style="western"><surname>Xia</surname><given-names>R</given-names></name><name name-style="western"><surname>Lu</surname><given-names>KH</given-names></name><name name-style="western"><surname>Li</surname><given-names>JH</given-names></name><name name-style="western"><surname>De</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>KM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZX</given-names></name></person-group><article-title>Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer</article-title><source>Mol Cancer</source><year>2014</year><volume>13</volume><fpage>92</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1476-4598-13-92">https://doi.org/10.1186/1476-4598-13-92</ext-link></comment><pub-id pub-id-type="pmid">24775712</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tong</surname><given-names>X</given-names></name></person-group><article-title>LncRNA HOTAIR controls the expression of Rab22a by sponging miR-373 in ovarian cancer</article-title><source>Mol Med Rep</source><year>2016</year><volume>14</volume><fpage>2465</fpage><lpage>72</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/mmr.2016.5572">https://doi.org/10.3892/mmr.2016.5572</ext-link></comment><pub-id pub-id-type="pmid">27484896</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>QY</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Han</surname><given-names>Q</given-names></name></person-group><article-title>Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140</article-title><source>Am J Transl Res</source><year>2016</year><volume>8</volume><fpage>3939</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">27725873</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>W</given-names></name><name name-style="western"><surname>Yu</surname><given-names>G</given-names></name><name name-style="western"><surname>Yao</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><etal/></person-group><article-title>LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>38005</fpage><lpage>15</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.5357">https://doi.org/10.18632/oncotarget.5357</ext-link></comment><pub-id pub-id-type="pmid">26461224</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Long non-coding RNA MALAT1 interacted with miR-204 to modulates human hilar cholangiocarcinoma proliferation, migration and invasion by targeting CXCR4</article-title><source>J Cell Biochem</source><year>2017</year><volume>118</volume><fpage>3643</fpage><lpage>53</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcb.25862">https://doi.org/10.1002/jcb.25862</ext-link></comment><pub-id pub-id-type="pmid">28059437</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>CC</given-names></name><name name-style="western"><surname>Li</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Hua</surname><given-names>RX</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>XH</given-names></name><name name-style="western"><surname>Li</surname><given-names>DJ</given-names></name></person-group><article-title>Long intergenic noncoding RNA 00511 acts as an oncogene in non-small-cell lung cancer by binding to EZH2 and suppressing p57</article-title><source>Mol Ther Nucleic Acids</source><year>2016</year><volume>5</volume><fpage>e385</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/mtna.2016.94">https://doi.org/10.1038/mtna.2016.94</ext-link></comment><pub-id pub-id-type="pmid">27845772</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>MD</given-names></name><name name-style="western"><surname>Weng</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JD</given-names></name><name name-style="western"><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>37857</fpage><lpage>67</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.9347">https://doi.org/10.18632/oncotarget.9347</ext-link></comment><pub-id pub-id-type="pmid">27191262</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>M</given-names></name><name name-style="western"><surname>Pang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway</article-title><source>Cancer Sci</source><year>2016</year><volume>107</volume><fpage>18</fpage><lpage>27</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cas.12844">https://doi.org/10.1111/cas.12844</ext-link></comment><pub-id pub-id-type="pmid">26544536</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>W</given-names></name><name name-style="western"><surname>Ge</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Tao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WS</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name></person-group><article-title>LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p</article-title><source>Cancer Lett</source><year>2016</year><volume>371</volume><fpage>99</fpage><lpage>106</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2015.11.024">https://doi.org/10.1016/j.canlet.2015.11.024</ext-link></comment><pub-id pub-id-type="pmid">26655272</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ying</surname><given-names>HQ</given-names></name><name name-style="western"><surname>He</surname><given-names>BS</given-names></name><name name-style="western"><surname>Pan</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Deng</surname><given-names>QW</given-names></name><name name-style="western"><surname>Sun</surname><given-names>HL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SK</given-names></name></person-group><article-title>Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>7899</fpage><lpage>917</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.3219">https://doi.org/10.18632/oncotarget.3219</ext-link></comment><pub-id pub-id-type="pmid">25760077</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>W</given-names></name></person-group><article-title>UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>10633</fpage><lpage>41</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-016-4917-1">https://doi.org/10.1007/s13277-016-4917-1</ext-link></comment><pub-id pub-id-type="pmid">26867765</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>LK</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>QY</given-names></name><name name-style="western"><surname>Wu</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Qu</surname><given-names>ZQ</given-names></name></person-group><article-title>MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2203</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2016.100">https://doi.org/10.1038/cddis.2016.100</ext-link></comment><pub-id pub-id-type="pmid">27100897</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>DL</given-names></name><name name-style="western"><surname>Ju</surname><given-names>HQ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>YX</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LZ</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>DS</given-names></name><name name-style="western"><surname>Luo</surname><given-names>HY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>DS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>DZ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>ZW</given-names></name><name name-style="western"><surname>Pelicano</surname><given-names>H</given-names></name><etal/></person-group><article-title>Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression</article-title><source>J Exp Clin Cancer Res</source><year>2016</year><volume>35</volume><fpage>142</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13046-016-0420-1">https://doi.org/10.1186/s13046-016-0420-1</ext-link></comment><pub-id pub-id-type="pmid">27620004</pub-id></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>SP</given-names></name><name name-style="western"><surname>Xu</surname><given-names>HX</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>JD</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>HM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>RX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shen</surname><given-names>ZY</given-names></name></person-group><article-title>LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>42431</fpage><lpage>46</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.9883">https://doi.org/10.18632/oncotarget.9883</ext-link></comment><pub-id pub-id-type="pmid">27285757</pub-id></element-citation></ref><ref id="R115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eades</surname><given-names>G</given-names></name><name name-style="western"><surname>Wolfson</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name></person-group><article-title>lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6</article-title><source>Mol Cancer Res</source><year>2015</year><volume>13</volume><fpage>330</fpage><lpage>38</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1541-7786.MCR-14-0251">https://doi.org/10.1158/1541-7786.MCR-14-0251</ext-link></comment><pub-id pub-id-type="pmid">25253741</pub-id></element-citation></ref><ref id="R116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>JH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JF</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TT</given-names></name><name name-style="western"><surname>Ma</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>CC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>WP</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SH</given-names></name></person-group><article-title>Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>5422</fpage><lpage>34</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2016.80">https://doi.org/10.1038/onc.2016.80</ext-link></comment><pub-id pub-id-type="pmid">27065331</pub-id></element-citation></ref><ref id="R117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>JH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>XG</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>SH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>DH</given-names></name></person-group><article-title>Long non-coding RNA NEAT1 promotes malignant progression of thyroid carcinoma by regulating miRNA-214</article-title><source>Int J Oncol</source><year>2017</year><volume>50</volume><fpage>708</fpage><lpage>16</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/ijo.2016.3803">https://doi.org/10.3892/ijo.2016.3803</ext-link></comment><pub-id pub-id-type="pmid">28000845</pub-id></element-citation></ref><ref id="R118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Xi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name></person-group><article-title>Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>51784</fpage><lpage>814</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.10108">https://doi.org/10.18632/oncotarget.10108</ext-link></comment><pub-id pub-id-type="pmid">27351135</pub-id></element-citation></ref><ref id="R119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>C</given-names></name><name name-style="western"><surname>Geng</surname><given-names>L</given-names></name><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/&#x003b2;-catenin signaling pathway</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>17785</fpage><lpage>94</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.14854">https://doi.org/10.18632/oncotarget.14854</ext-link></comment><pub-id pub-id-type="pmid">28147312</pub-id></element-citation></ref><ref id="R120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Jin</surname><given-names>LY</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Quan</surname><given-names>ZW</given-names></name></person-group><article-title>Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>88</volume><fpage>863</fpage><lpage>69</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biopha.2017.01.150">https://doi.org/10.1016/j.biopha.2017.01.150</ext-link></comment><pub-id pub-id-type="pmid">28178615</pub-id></element-citation></ref><ref id="R121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yao</surname><given-names>B</given-names></name><name name-style="western"><surname>Dou</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tu</surname><given-names>K</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>11429</fpage><lpage>41</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-016-4892-6">https://doi.org/10.1007/s13277-016-4892-6</ext-link></comment><pub-id pub-id-type="pmid">27002617</pub-id></element-citation></ref><ref id="R122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattick</surname><given-names>JS</given-names></name></person-group><article-title>Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms</article-title><source>BioEssays</source><year>2003</year><volume>25</volume><fpage>930</fpage><lpage>39</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/bies.10332">https://doi.org/10.1002/bies.10332</ext-link></comment><pub-id pub-id-type="pmid">14505360</pub-id></element-citation></ref><ref id="R123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prensner</surname><given-names>JR</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>MK</given-names></name><name name-style="western"><surname>Sahu</surname><given-names>A</given-names></name><name name-style="western"><surname>Asangani</surname><given-names>IA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Patel</surname><given-names>L</given-names></name><name name-style="western"><surname>Vergara</surname><given-names>IA</given-names></name><name name-style="western"><surname>Davicioni</surname><given-names>E</given-names></name><name name-style="western"><surname>Erho</surname><given-names>N</given-names></name><name name-style="western"><surname>Ghadessi</surname><given-names>M</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>RB</given-names></name><name name-style="western"><surname>Triche</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Malik</surname><given-names>R</given-names></name><etal/></person-group><article-title>The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>1392</fpage><lpage>98</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2771">https://doi.org/10.1038/ng.2771</ext-link></comment><pub-id pub-id-type="pmid">24076601</pub-id></element-citation></ref><ref id="R124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>RR</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>T</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>F</given-names></name><name name-style="western"><surname>Enroth</surname><given-names>S</given-names></name><name name-style="western"><surname>Redrup</surname><given-names>L</given-names></name><name name-style="western"><surname>Komorowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Nagano</surname><given-names>T</given-names></name><name name-style="western"><surname>Mancini-Dinardo</surname><given-names>D</given-names></name><name name-style="western"><surname>Kanduri</surname><given-names>C</given-names></name></person-group><article-title>Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation</article-title><source>Mol Cell</source><year>2008</year><volume>32</volume><fpage>232</fpage><lpage>46</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2008.08.022">https://doi.org/10.1016/j.molcel.2008.08.022</ext-link></comment><pub-id pub-id-type="pmid">18951091</pub-id></element-citation></ref><ref id="R125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kotake</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Kitagawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Kitagawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name></person-group><article-title>Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene</article-title><source>Oncogene</source><year>2011</year><volume>30</volume><fpage>1956</fpage><lpage>62</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2010.568">https://doi.org/10.1038/onc.2010.568</ext-link></comment><pub-id pub-id-type="pmid">21151178</pub-id></element-citation></ref><ref id="R126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yap</surname><given-names>KL</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Mu&#x000f1;oz-Cabello</surname><given-names>AM</given-names></name><name name-style="western"><surname>Raguz</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name><name name-style="western"><surname>Mujtaba</surname><given-names>S</given-names></name><name name-style="western"><surname>Gil</surname><given-names>J</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>MM</given-names></name></person-group><article-title>Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a</article-title><source>Mol Cell</source><year>2010</year><volume>38</volume><fpage>662</fpage><lpage>74</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2010.03.021">https://doi.org/10.1016/j.molcel.2010.03.021</ext-link></comment><pub-id pub-id-type="pmid">20541999</pub-id></element-citation></ref><ref id="R127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>MC</given-names></name><name name-style="western"><surname>Manor</surname><given-names>O</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mosammaparast</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JK</given-names></name><name name-style="western"><surname>Lan</surname><given-names>F</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Segal</surname><given-names>E</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name></person-group><article-title>Long noncoding RNA as modular scaffold of histone modification complexes</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>689</fpage><lpage>93</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1192002">https://doi.org/10.1126/science.1192002</ext-link></comment><pub-id pub-id-type="pmid">20616235</pub-id></element-citation></ref><ref id="R128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruthenburg</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Graybosch</surname><given-names>DM</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Allis</surname><given-names>CD</given-names></name><name name-style="western"><surname>Patel</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Verdine</surname><given-names>GL</given-names></name></person-group><article-title>Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex</article-title><source>Nat Struct Mol Biol</source><year>2006</year><volume>13</volume><fpage>704</fpage><lpage>12</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nsmb1119">https://doi.org/10.1038/nsmb1119</ext-link></comment><pub-id pub-id-type="pmid">16829959</pub-id></element-citation></ref><ref id="R129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margueron</surname><given-names>R</given-names></name><name name-style="western"><surname>Reinberg</surname><given-names>D</given-names></name></person-group><article-title>The Polycomb complex PRC2 and its mark in life</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>343</fpage><lpage>49</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature09784">https://doi.org/10.1038/nature09784</ext-link></comment><pub-id pub-id-type="pmid">21248841</pub-id></element-citation></ref><ref id="R130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>RA</given-names></name><name name-style="western"><surname>Shah</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>KC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Horlings</surname><given-names>HM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hung</surname><given-names>T</given-names></name><name name-style="western"><surname>Argani</surname><given-names>P</given-names></name><name name-style="western"><surname>Rinn</surname><given-names>JL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brzoska</surname><given-names>P</given-names></name><name name-style="western"><surname>Kong</surname><given-names>B</given-names></name><etal/></person-group><article-title>Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>1071</fpage><lpage>76</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature08975">https://doi.org/10.1038/nature08975</ext-link></comment><pub-id pub-id-type="pmid">20393566</pub-id></element-citation></ref><ref id="R131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>YW</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Xia</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>EB</given-names></name><name name-style="western"><surname>Liu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Xu</surname><given-names>TP</given-names></name><name name-style="western"><surname>De</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>BR</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZX</given-names></name></person-group><article-title>LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1802</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2015.150">https://doi.org/10.1038/cddis.2015.150</ext-link></comment><pub-id pub-id-type="pmid">26136075</pub-id></element-citation></ref><ref id="R132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>NK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WK</given-names></name><name name-style="western"><surname>Yun</surname><given-names>S</given-names></name><name name-style="western"><surname>Youn</surname><given-names>YH</given-names></name><name name-style="western"><surname>Park</surname><given-names>CH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>YY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SK</given-names></name></person-group><article-title>Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>75307</fpage><lpage>18</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.12171">https://doi.org/10.18632/oncotarget.12171</ext-link></comment><pub-id pub-id-type="pmid">27659532</pub-id></element-citation></ref><ref id="R133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Ren</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>F</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Hao</surname><given-names>X</given-names></name></person-group><article-title>Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma</article-title><source>Int J Oncol</source><year>2015</year><volume>46</volume><fpage>2586</fpage><lpage>94</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/ijo.2015.2976">https://doi.org/10.3892/ijo.2015.2976</ext-link></comment><pub-id pub-id-type="pmid">25901533</pub-id></element-citation></ref><ref id="R134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Nie</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hou</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Xie</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>De</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1</article-title><source>Cancer Res</source><year>2016</year><volume>76</volume><fpage>6299</fpage><lpage>310</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-16-0356">https://doi.org/10.1158/0008-5472.CAN-16-0356</ext-link></comment><pub-id pub-id-type="pmid">27651312</pub-id></element-citation></ref><ref id="R135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sui</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>YM</given-names></name><name name-style="western"><surname>Shen</surname><given-names>WF</given-names></name><name name-style="western"><surname>Dai</surname><given-names>BH</given-names></name><name name-style="western"><surname>Lu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>MF</given-names></name><name name-style="western"><surname>Yang</surname><given-names>JM</given-names></name></person-group><article-title>Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429</article-title><source>J Mol Med (Berl)</source><year>2016</year><volume>94</volume><fpage>1281</fpage><lpage>96</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00109-016-1442-z">https://doi.org/10.1007/s00109-016-1442-z</ext-link></comment><pub-id pub-id-type="pmid">27380494</pub-id></element-citation></ref><ref id="R136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Zang</surname><given-names>C</given-names></name><name name-style="western"><surname>Ma</surname><given-names>P</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shu</surname><given-names>Y</given-names></name></person-group><article-title>Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2225</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cddis.2016.126">https://doi.org/10.1038/cddis.2016.126</ext-link></comment><pub-id pub-id-type="pmid">27195672</pub-id></element-citation></ref><ref id="R137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reisman</surname><given-names>D</given-names></name><name name-style="western"><surname>Glaros</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name></person-group><article-title>The SWI/SNF complex and cancer</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>1653</fpage><lpage>68</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2009.4">https://doi.org/10.1038/onc.2009.4</ext-link></comment><pub-id pub-id-type="pmid">19234488</pub-id></element-citation></ref><ref id="R138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milne</surname><given-names>TA</given-names></name><name name-style="western"><surname>Briggs</surname><given-names>SD</given-names></name><name name-style="western"><surname>Brock</surname><given-names>HW</given-names></name><name name-style="western"><surname>Martin</surname><given-names>ME</given-names></name><name name-style="western"><surname>Gibbs</surname><given-names>D</given-names></name><name name-style="western"><surname>Allis</surname><given-names>CD</given-names></name><name name-style="western"><surname>Hess</surname><given-names>JL</given-names></name></person-group><article-title>MLL targets SET domain methyltransferase activity to Hox gene promoters</article-title><source>Mol Cell</source><year>2002</year><volume>10</volume><fpage>1107</fpage><lpage>17</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1097-2765(02)00741-4">https://doi.org/10.1016/S1097-2765(02)00741-4</ext-link></comment><pub-id pub-id-type="pmid">12453418</pub-id></element-citation></ref><ref id="R139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nombela</surname><given-names>C</given-names></name><name name-style="western"><surname>Nombela</surname><given-names>NA</given-names></name><name name-style="western"><surname>Ochoa</surname><given-names>S</given-names></name><name name-style="western"><surname>Safer</surname><given-names>B</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>WF</given-names></name><name name-style="western"><surname>Merrick</surname><given-names>WC</given-names></name></person-group><article-title>Polypeptide chain initiation in eukaryotes: mechanism of formation of initiation complex</article-title><source>Proc Natl Acad Sci USA</source><year>1976</year><volume>73</volume><fpage>298</fpage><lpage>301</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.73.2.298">https://doi.org/10.1073/pnas.73.2.298</ext-link></comment><pub-id pub-id-type="pmid">1061132</pub-id></element-citation></ref><ref id="R140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>R</given-names></name><name name-style="western"><surname>Tiu</surname><given-names>B</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>KM</given-names></name></person-group><article-title>CBP/p300 acetyltransferase activity in hematologic malignancies</article-title><source>Mol Genet Metab</source><year>2016</year><volume>119</volume><fpage>37</fpage><lpage>43</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ymgme.2016.06.013">https://doi.org/10.1016/j.ymgme.2016.06.013</ext-link></comment><pub-id pub-id-type="pmid">27380996</pub-id></element-citation></ref><ref id="R141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Man</surname><given-names>N</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nimer</surname><given-names>SD</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>The role of histone acetyltransferases in normal and malignant hematopoiesis</article-title><source>Front Oncol</source><year>2015</year><volume>5</volume><fpage>108</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fonc.2015.00108">https://doi.org/10.3389/fonc.2015.00108</ext-link></comment><pub-id pub-id-type="pmid">26075180</pub-id></element-citation></ref><ref id="R142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name></person-group><article-title>Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1</article-title><source>Am J Transl Res</source><year>2016</year><volume>8</volume><fpage>4095</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">27829995</pub-id></element-citation></ref><ref id="R143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>K</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>CE</given-names></name><name name-style="western"><surname>Buquicchio</surname><given-names>F</given-names></name><name name-style="western"><surname>Brown</surname><given-names>A</given-names></name><name name-style="western"><surname>Ritz</surname><given-names>J</given-names></name><name name-style="western"><surname>Distel</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>CH</given-names></name><name name-style="western"><surname>Novina</surname><given-names>CD</given-names></name></person-group><article-title>The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region</article-title><source>Cell Reports</source><year>2016</year><volume>15</volume><fpage>2025</fpage><lpage>37</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.04.018">https://doi.org/10.1016/j.celrep.2016.04.018</ext-link></comment><pub-id pub-id-type="pmid">27210747</pub-id></element-citation></ref><ref id="R144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Liang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Park</surname><given-names>PK</given-names></name><name name-style="western"><surname>Qin</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hawke</surname><given-names>DH</given-names></name><name name-style="western"><surname>Hung</surname><given-names>MC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name></person-group><article-title>lncRNA directs cooperative epigenetic regulation downstream of chemokine signals</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1110</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2014.10.013">https://doi.org/10.1016/j.cell.2014.10.013</ext-link></comment><pub-id pub-id-type="pmid">25416949</pub-id></element-citation></ref><ref id="R145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Han</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sui</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Hou</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name></person-group><article-title>Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex</article-title><source>Br J Cancer</source><year>2014</year><volume>111</volume><fpage>736</fpage><lpage>48</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/bjc.2014.383">https://doi.org/10.1038/bjc.2014.383</ext-link></comment><pub-id pub-id-type="pmid">25025966</pub-id></element-citation></ref><ref id="R146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glickman</surname><given-names>MH</given-names></name><name name-style="western"><surname>Ciechanover</surname><given-names>A</given-names></name></person-group><article-title>The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction</article-title><source>Physiol Rev</source><year>2002</year><volume>82</volume><fpage>373</fpage><lpage>428</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00027.2001">https://doi.org/10.1152/physrev.00027.2001</ext-link></comment><pub-id pub-id-type="pmid">11917093</pub-id></element-citation></ref><ref id="R147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kretz</surname><given-names>M</given-names></name><name name-style="western"><surname>Siprashvili</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chu</surname><given-names>C</given-names></name><name name-style="western"><surname>Webster</surname><given-names>DE</given-names></name><name name-style="western"><surname>Zehnder</surname><given-names>A</given-names></name><name name-style="western"><surname>Qu</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CS</given-names></name><name name-style="western"><surname>Flockhart</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Groff</surname><given-names>AF</given-names></name><name name-style="western"><surname>Chow</surname><given-names>J</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>GE</given-names></name><name name-style="western"><surname>Spitale</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Control of somatic tissue differentiation by the long non-coding RNA TINCR</article-title><source>Nature</source><year>2013</year><volume>493</volume><fpage>231</fpage><lpage>35</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature11661">https://doi.org/10.1038/nature11661</ext-link></comment><pub-id pub-id-type="pmid">23201690</pub-id></element-citation></ref><ref id="R148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maetzel</surname><given-names>D</given-names></name><name name-style="western"><surname>Denzel</surname><given-names>S</given-names></name><name name-style="western"><surname>Mack</surname><given-names>B</given-names></name><name name-style="western"><surname>Canis</surname><given-names>M</given-names></name><name name-style="western"><surname>Went</surname><given-names>P</given-names></name><name name-style="western"><surname>Benk</surname><given-names>M</given-names></name><name name-style="western"><surname>Kieu</surname><given-names>C</given-names></name><name name-style="western"><surname>Papior</surname><given-names>P</given-names></name><name name-style="western"><surname>Baeuerle</surname><given-names>PA</given-names></name><name name-style="western"><surname>Munz</surname><given-names>M</given-names></name><name name-style="western"><surname>Gires</surname><given-names>O</given-names></name></person-group><article-title>Nuclear signalling by tumour-associated antigen EpCAM</article-title><source>Nat Cell Biol</source><year>2009</year><volume>11</volume><fpage>162</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1824">https://doi.org/10.1038/ncb1824</ext-link></comment><pub-id pub-id-type="pmid">19136966</pub-id></element-citation></ref><ref id="R149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Huo</surname><given-names>XS</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>SX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>WP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SH</given-names></name></person-group><article-title>Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis</article-title><source>Mol Cell</source><year>2013</year><volume>49</volume><fpage>1083</fpage><lpage>96</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2013.01.010">https://doi.org/10.1016/j.molcel.2013.01.010</ext-link></comment><pub-id pub-id-type="pmid">23395002</pub-id></element-citation></ref><ref id="R150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuwano</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pullmann</surname><given-names>R</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Marasa</surname><given-names>BS</given-names></name><name name-style="western"><surname>Abdelmohsen</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EK</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Martindale</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>M</given-names></name><name name-style="western"><surname>Gorospe</surname><given-names>M</given-names></name></person-group><article-title>NF90 selectively represses the translation of target mRNAs bearing an AU-rich signature motif</article-title><source>Nucleic Acids Res</source><year>2010</year><volume>38</volume><fpage>225</fpage><lpage>38</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkp861">https://doi.org/10.1093/nar/gkp861</ext-link></comment><pub-id pub-id-type="pmid">19850717</pub-id></element-citation></ref><ref id="R151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#x000e1;nchez-Till&#x000f3;</surname><given-names>E</given-names></name><name name-style="western"><surname>L&#x000e1;zaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Torrent</surname><given-names>R</given-names></name><name name-style="western"><surname>Cuatrecasas</surname><given-names>M</given-names></name><name name-style="western"><surname>Vaquero</surname><given-names>EC</given-names></name><name name-style="western"><surname>Castells</surname><given-names>A</given-names></name><name name-style="western"><surname>Engel</surname><given-names>P</given-names></name><name name-style="western"><surname>Postigo</surname><given-names>A</given-names></name></person-group><article-title>ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>3490</fpage><lpage>500</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2010.102">https://doi.org/10.1038/onc.2010.102</ext-link></comment><pub-id pub-id-type="pmid">20418909</pub-id></element-citation></ref><ref id="R152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Postigo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Dean</surname><given-names>DC</given-names></name></person-group><article-title>ZEB represses transcription through interaction with the corepressor CtBP</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>6683</fpage><lpage>88</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.96.12.6683">https://doi.org/10.1073/pnas.96.12.6683</ext-link></comment><pub-id pub-id-type="pmid">10359772</pub-id></element-citation></ref><ref id="R153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>TH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>CT</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YL</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>TH</given-names></name><name name-style="western"><surname>Shieh</surname><given-names>TM</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>TC</given-names></name></person-group><article-title>Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>23342</fpage><lpage>57</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.4344">https://doi.org/10.18632/oncotarget.4344</ext-link></comment><pub-id pub-id-type="pmid">26160837</pub-id></element-citation></ref><ref id="R154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruland</surname><given-names>J</given-names></name></person-group><article-title>Return to homeostasis: downregulation of NF-&#x003ba;B responses</article-title><source>Nat Immunol</source><year>2011</year><volume>12</volume><fpage>709</fpage><lpage>14</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ni.2055">https://doi.org/10.1038/ni.2055</ext-link></comment><pub-id pub-id-type="pmid">21772279</pub-id></element-citation></ref><ref id="R155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaturvedi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Sung</surname><given-names>B</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>VR</given-names></name><name name-style="western"><surname>Kannappan</surname><given-names>R</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group><article-title>NF-&#x003ba;B addiction and its role in cancer: &#x02018;one size does not fit all&#x02019;</article-title><source>Oncogene</source><year>2011</year><volume>30</volume><fpage>1615</fpage><lpage>30</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/onc.2010.566">https://doi.org/10.1038/onc.2010.566</ext-link></comment><pub-id pub-id-type="pmid">21170083</pub-id></element-citation></ref><ref id="R156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fornier</surname><given-names>MN</given-names></name><name name-style="western"><surname>Rathkopf</surname><given-names>D</given-names></name><name name-style="western"><surname>Shah</surname><given-names>M</given-names></name><name name-style="western"><surname>Patil</surname><given-names>S</given-names></name><name name-style="western"><surname>O&#x02019;Reilly</surname><given-names>E</given-names></name><name name-style="western"><surname>Tse</surname><given-names>AN</given-names></name><name name-style="western"><surname>Hudis</surname><given-names>C</given-names></name><name name-style="western"><surname>Lefkowitz</surname><given-names>R</given-names></name><name name-style="western"><surname>Kelsen</surname><given-names>DP</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>GK</given-names></name></person-group><article-title>Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors</article-title><source>Clin Cancer Res</source><year>2007</year><volume>13</volume><fpage>5841</fpage><lpage>46</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-07-1218">https://doi.org/10.1158/1078-0432.CCR-07-1218</ext-link></comment><pub-id pub-id-type="pmid">17908977</pub-id></element-citation></ref><ref id="R157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gong</surname><given-names>C</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lv</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Yao</surname><given-names>H</given-names></name><name name-style="western"><surname>Su</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>M</given-names></name><name name-style="western"><surname>Song</surname><given-names>E</given-names></name></person-group><article-title>A cytoplasmic NF-&#x003ba;B interacting long noncoding RNA blocks I&#x003ba;B phosphorylation and suppresses breast cancer metastasis</article-title><source>Cancer Cell</source><year>2015</year><volume>27</volume><fpage>370</fpage><lpage>81</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccell.2015.02.004">https://doi.org/10.1016/j.ccell.2015.02.004</ext-link></comment><pub-id pub-id-type="pmid">25759022</pub-id></element-citation></ref><ref id="R158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>L</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>XF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>ZY</given-names></name><etal/></person-group><article-title>Exosome-transmitted lncarsr promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA</article-title><source>Cancer Cell</source><year>2016</year><volume>29</volume><fpage>653</fpage><lpage>68</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ccell.2016.03.004">https://doi.org/10.1016/j.ccell.2016.03.004</ext-link></comment><pub-id pub-id-type="pmid">27117758</pub-id></element-citation></ref><ref id="R159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chimge</surname><given-names>NO</given-names></name><name name-style="western"><surname>Baniwal</surname><given-names>SK</given-names></name><name name-style="western"><surname>Little</surname><given-names>GH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YB</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>M</given-names></name><name name-style="western"><surname>Tripathy</surname><given-names>D</given-names></name><name name-style="western"><surname>Borok</surname><given-names>Z</given-names></name><name name-style="western"><surname>Frenkel</surname><given-names>B</given-names></name></person-group><article-title>Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2</article-title><source>Breast Cancer Res</source><year>2011</year><volume>13</volume><fpage>R127</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/bcr3073">https://doi.org/10.1186/bcr3073</ext-link></comment><pub-id pub-id-type="pmid">22151997</pub-id></element-citation></ref><ref id="R160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katafiasz</surname><given-names>D</given-names></name><name name-style="western"><surname>Smith</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wahl</surname><given-names>JK</given-names><suffix>3rd</suffix></name></person-group><article-title>Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility</article-title><source>Cell Adhes Migr</source><year>2011</year><volume>5</volume><fpage>315</fpage><lpage>22</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4161/cam.5.4.17040">https://doi.org/10.4161/cam.5.4.17040</ext-link></comment></element-citation></ref><ref id="R161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W</given-names></name><name name-style="western"><surname>Hou</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name></person-group><article-title>Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma</article-title><source>Int J Cancer</source><year>2012</year><volume>130</volume><fpage>2249</fpage><lpage>58</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.26226">https://doi.org/10.1002/ijc.26226</ext-link></comment><pub-id pub-id-type="pmid">21647877</pub-id></element-citation></ref><ref id="R162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Dang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name></person-group><article-title>LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>16345</fpage><lpage>55</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-016-5448-5">https://doi.org/10.1007/s13277-016-5448-5</ext-link></comment></element-citation></ref><ref id="R163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>B</given-names></name><name name-style="western"><surname>Cai</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Fang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name></person-group><article-title>Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer</article-title><source>Mol Ther</source><year>2016</year><volume>24</volume><fpage>2064</fpage><lpage>77</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/mt.2016.180">https://doi.org/10.1038/mt.2016.180</ext-link></comment><pub-id pub-id-type="pmid">27633443</pub-id></element-citation></ref><ref id="R164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Du</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2</article-title><source>Mol Cancer Ther</source><year>2017</year><volume>16</volume><fpage>739</fpage><lpage>51</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1535-7163.MCT-16-0591">https://doi.org/10.1158/1535-7163.MCT-16-0591</ext-link></comment><pub-id pub-id-type="pmid">28069878</pub-id></element-citation></ref><ref id="R165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhi</surname><given-names>X</given-names></name></person-group><article-title>Long non-coding RNA (LncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b</article-title><source>Med Sci Monit</source><year>2016</year><volume>22</volume><fpage>3506</fpage><lpage>13</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.12659/MSM.900688">https://doi.org/10.12659/MSM.900688</ext-link></comment><pub-id pub-id-type="pmid">27694794</pub-id></element-citation></ref><ref id="R166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>C</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name></person-group><article-title>Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer</article-title><source>Cancer Chemother Pharmacol</source><year>2016</year><volume>77</volume><fpage>1061</fpage><lpage>67</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00280-016-3029-3">https://doi.org/10.1007/s00280-016-3029-3</ext-link></comment><pub-id pub-id-type="pmid">27056384</pub-id></element-citation></ref><ref id="R167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Yan</surname><given-names>IK</given-names></name><name name-style="western"><surname>Kogure</surname><given-names>T</given-names></name><name name-style="western"><surname>Haga</surname><given-names>H</given-names></name><name name-style="western"><surname>Patel</surname><given-names>T</given-names></name></person-group><article-title>Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer</article-title><source>FEBS Open Bio</source><year>2014</year><volume>4</volume><fpage>458</fpage><lpage>67</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.fob.2014.04.007">https://doi.org/10.1016/j.fob.2014.04.007</ext-link></comment></element-citation></ref><ref id="R168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Svoboda</surname><given-names>M</given-names></name><name name-style="western"><surname>Slyskova</surname><given-names>J</given-names></name><name name-style="western"><surname>Schneiderova</surname><given-names>M</given-names></name><name name-style="western"><surname>Makovicky</surname><given-names>P</given-names></name><name name-style="western"><surname>Bielik</surname><given-names>L</given-names></name><name name-style="western"><surname>Levy</surname><given-names>M</given-names></name><name name-style="western"><surname>Lipska</surname><given-names>L</given-names></name><name name-style="western"><surname>Hemmelova</surname><given-names>B</given-names></name><name name-style="western"><surname>Kala</surname><given-names>Z</given-names></name><name name-style="western"><surname>Protivankova</surname><given-names>M</given-names></name><name name-style="western"><surname>Vycital</surname><given-names>O</given-names></name><name name-style="western"><surname>Liska</surname><given-names>V</given-names></name><name name-style="western"><surname>Schwarzova</surname><given-names>L</given-names></name><etal/></person-group><article-title>HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients</article-title><source>Carcinogenesis</source><year>2014</year><volume>35</volume><fpage>1510</fpage><lpage>15</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/carcin/bgu055">https://doi.org/10.1093/carcin/bgu055</ext-link></comment><pub-id pub-id-type="pmid">24583926</pub-id></element-citation></ref><ref id="R169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>F</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name></person-group><article-title>Expression of MALAT1 in the peripheral whole blood of patients with lung cancer</article-title><source>Biomed Rep</source><year>2015</year><volume>3</volume><fpage>309</fpage><lpage>12</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/br.2015.422">https://doi.org/10.3892/br.2015.422</ext-link></comment><pub-id pub-id-type="pmid">26137228</pub-id></element-citation></ref><ref id="R170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name></person-group><article-title>Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma</article-title><source>BioMed Res Int</source><year>2013</year><volume>2013</volume><fpage>136106</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2013/136106">https://doi.org/10.1155/2013/136106</ext-link></comment><pub-id pub-id-type="pmid">23762823</pub-id></element-citation></ref><ref id="R171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name></person-group><article-title>Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and <italic>in vitro</italic> investigation</article-title><source>Oncol Rep</source><year>2014</year><volume>31</volume><fpage>358</fpage><lpage>64</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/or.2013.2850">https://doi.org/10.3892/or.2013.2850</ext-link></comment><pub-id pub-id-type="pmid">24247585</pub-id></element-citation></ref><ref id="R172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>P</given-names></name><name name-style="western"><surname>Chu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Lv</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gong</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Su</surname><given-names>S</given-names></name></person-group><article-title>NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>32410</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.5609">https://doi.org/10.18632/oncotarget.5609</ext-link></comment><pub-id pub-id-type="pmid">26378045</pub-id></element-citation></ref><ref id="R173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Tang</surname><given-names>XS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Guo</surname><given-names>P</given-names></name></person-group><article-title>Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>37868</fpage><lpage>81</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.9350">https://doi.org/10.18632/oncotarget.9350</ext-link></comment><pub-id pub-id-type="pmid">27191265</pub-id></element-citation></ref><ref id="R174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>W</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T</given-names></name></person-group><article-title>linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer</article-title><source>Biochim Biophys Acta</source><year>2013</year><volume>1832</volume><fpage>1528</fpage><lpage>37</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbadis.2013.05.010">https://doi.org/10.1016/j.bbadis.2013.05.010</ext-link></comment><pub-id pub-id-type="pmid">23688781</pub-id></element-citation></ref><ref id="R175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>NX</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SB</given-names></name><name name-style="western"><surname>Jin</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e100340</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0100340">https://doi.org/10.1371/journal.pone.0100340</ext-link></comment><pub-id pub-id-type="pmid">25007342</pub-id></element-citation></ref><ref id="R176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J</given-names></name><name name-style="western"><surname>Tian</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297</article-title><source>Cancer Cell Int</source><year>2017</year><volume>17</volume><fpage>44</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12935-017-0408-8">https://doi.org/10.1186/s12935-017-0408-8</ext-link></comment><pub-id pub-id-type="pmid">28396617</pub-id></element-citation></ref><ref id="R177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>HS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Tan</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>YY</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><etal/></person-group><article-title>MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>12693</fpage><lpage>703</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.7281">https://doi.org/10.18632/oncotarget.7281</ext-link></comment><pub-id pub-id-type="pmid">26871474</pub-id></element-citation></ref><ref id="R178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hou</surname><given-names>P</given-names></name><name name-style="western"><surname>Fan</surname><given-names>D</given-names></name><name name-style="western"><surname>Dong</surname><given-names>M</given-names></name><name name-style="western"><surname>Ma</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Yao</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Geng</surname><given-names>P</given-names></name><name name-style="western"><surname>Mihretab</surname><given-names>A</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>59</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cdd.2016.95PMID:27716745">https://doi.org/10.1038/cdd.2016.95 PMID:27716745</ext-link></comment><pub-id pub-id-type="pmid">27716745</pub-id></element-citation></ref><ref id="R179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Lv</surname><given-names>P</given-names></name><name name-style="western"><surname>Dang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>JY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2</article-title><source>Am J Cancer Res</source><year>2016</year><volume>6</volume><fpage>2651</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">27904778</pub-id></element-citation></ref><ref id="R180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name></person-group><article-title>The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>9160</fpage><lpage>72</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.3247">https://doi.org/10.18632/oncotarget.3247</ext-link></comment><pub-id pub-id-type="pmid">25863539</pub-id></element-citation></ref><ref id="R181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CQ</given-names></name><name name-style="western"><surname>Peng</surname><given-names>CW</given-names></name><name name-style="western"><surname>Hou</surname><given-names>JX</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JY</given-names></name></person-group><article-title>Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression</article-title><source>Gene</source><year>2016</year><volume>592</volume><fpage>172</fpage><lpage>78</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gene.2016.08.002">https://doi.org/10.1016/j.gene.2016.08.002</ext-link></comment><pub-id pub-id-type="pmid">27496341</pub-id></element-citation></ref></ref-list></back></article>